{"id":43091,"date":"2015-09-17T11:25:58","date_gmt":"2015-09-17T16:25:58","guid":{"rendered":"https:\/\/content.findlaw-admin.com\/ability-legal\/contracts\/uncategorized\/agreement-and-plan-of-merger-merck-amp-co-inc-and.html"},"modified":"2015-09-17T11:25:58","modified_gmt":"2015-09-17T16:25:58","slug":"agreement-and-plan-of-merger-merck-amp-co-inc-and","status":"publish","type":"corporate_contracts","link":"https:\/\/corporate.findlaw.com\/contracts\/planning\/agreement-and-plan-of-merger-merck-amp-co-inc-and.html","title":{"rendered":"Agreement and Plan of Merger &#8211; Merck &#038; Co. Inc. and Provantage Health Services Inc."},"content":{"rendered":"<pre>\n                ==============================================\n\n                          AGREEMENT AND PLAN OF MERGER\n\n                                     among\n\n                               MERCK &amp; CO., INC.\n\n                              PV ACQUISITION CORP.\n\n                                      and\n\n                        PROVANTAGE HEALTH SERVICES, INC.\n\n\n                                  dated as of\n\n                                  May 4, 2000\n\n                ==============================================\n\n \n                               TABLE OF CONTENTS\n\n<\/pre>\n<table>\n<caption>\n<p>                                                                                   Page<br \/>\n                                                                                   &#8212;-<br \/>\n     <s>                                                                          <c><br \/>\nARTICLE 1  OFFER&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..  2<br \/>\n     Section 1.01. The Offer&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..  2<br \/>\n     Section 1.02. Company Actions&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..  4<br \/>\n     Section 1.03. Directors of the Company&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..  5<\/p>\n<p>ARTICLE 2  THE MERGER&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;  6<br \/>\n     Section 2.01. The Merger&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.  6<br \/>\n     Section 2.02. Closing&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.  6<br \/>\n     Section 2.03. Effective Time&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;  6<br \/>\n     Section 2.04. Effects of the Merger&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..  6<br \/>\n     Section 2.05. Certificate of Incorporation and Bylaws&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..  6<br \/>\n     Section 2.06. Directors and Officers&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.  7<br \/>\n     Section 2.07. Conversion of Shares&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;  7<br \/>\n     Section 2.08. Dissenting Shares&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;  7<br \/>\n     Section 2.09. Payments for Shares&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.  8<br \/>\n     Section 2.10. Stock Option and Other Plans&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.  9<\/p>\n<p>ARTICLE 3  REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUBSIDIARY&#8230;&#8230;.. 10<br \/>\n     Section 3.01. Corporate Existence and Power&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 10<br \/>\n     Section 3.02. Corporate Authority&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;. 10<br \/>\n     Section 3.03. Governmental Authorization&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 11<br \/>\n     Section 3.04. Non-contravention&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 11<br \/>\n     Section 3.05. Offer Documents; Proxy Statement; Schedule 14D-9&#8230;&#8230;&#8230;&#8230;.. 11<br \/>\n     Section 3.06. Financing&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.. 12<br \/>\n     Section 3.07. Finders&#8217; Fees&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;. 12<br \/>\n     Section 3.08. Delaware Law&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.. 12<\/p>\n<p>ARTICLE 4  REPRESENTATIONS AND WARRANTIES OF THE COMPANY &#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 12<br \/>\n     Section 4.01. Corporate Existence and Power&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 12<br \/>\n     Section 4.02. Corporate Authority&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;. 13<br \/>\n     Section 4.03. Governmental Authorization&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 13<br \/>\n     Section 4.04. Non-contravention&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 13<br \/>\n     Section 4.05. Capitalization&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 14<br \/>\n     Section 4.06. Subsidiaries&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.. 15<br \/>\n     Section 4.07. Company SEC Documents and Financial Statements&#8230;&#8230;&#8230;&#8230;&#8230;. 15<br \/>\n     Section 4.08. Schedule 14D-9; Offer Documents; and Proxy Statement&#8230;&#8230;&#8230;. 16<br \/>\n     Section 4.09. Absence of Certain Changes&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 16<br \/>\n     Section 4.10. Litigation&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;. 17<br \/>\n     Section 4.11. Proprietary Rights&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.. 17<br \/>\n     Section 4.12. Benefit Plans; ERISA&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 17<br \/>\n     Section 4.13. Environmental Matters&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.. 19<br \/>\n     Section 4.14. Taxes&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 19<br \/>\n     Section 4.15. Certain Approvals&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 20<\/p>\n<p><\/c><\/s><\/caption>\n<\/table>\n<p>                                      -i-<\/p>\n<table>\n<p>     <s>                                                                         <c><br \/>\n     Section 4.16. Opinion of Financial Advisor&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;. 20<br \/>\n     Section 4.17. Rights Plan&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 20<br \/>\n     Section 4.18. Fees and Commissions&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 20<br \/>\n     Section 4.19. Compliance; Permits&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;. 20<br \/>\n     Section 4.20. Contracts&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.. 20<br \/>\n     Section 4.21. Affiliate Transactions&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;. 21<br \/>\n     Section 4.22. Working Capital&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.. 21<\/p>\n<p>ARTICLE 5  COVENANTS&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;. 22<br \/>\n     Section 5.01. Conduct of Business of the Company&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;. 22<br \/>\n     Section 5.02. Acquisition Proposals&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.. 22<br \/>\n     Section 5.03. Access to Information&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.. 23<br \/>\n     Section 5.04. Commercially Reasonable Efforts&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;. 25<br \/>\n     Section 5.05. Indemnification Exculpation and Insurance&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 25<br \/>\n     Section 5.06. Employee Plans and Benefits and Employment Contracts&#8230;&#8230;&#8230;. 27<br \/>\n     Section 5.07. Meeting of the Company&#8217;s Stockholders&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;. 29<br \/>\n     Section 5.08. De-registration&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.. 30<br \/>\n     Section 5.09. Certain Actions&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.. 31<br \/>\n     Section 5.10. Affiliate Transactions&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;. 31<br \/>\n     Section 5.11. Public Announcements&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 32<br \/>\n     Section 5.12. Performance by Merger Subsidiary&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 32<\/p>\n<p>ARTICLE 6  CONDITIONS TO THE MERGER&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;. 33<br \/>\n     Section 6.01. Conditions to Each Party&#8217;s Obligation to Effect the Merger&#8230;. 33<\/p>\n<p>ARTICLE 7  TERMINATION; AMENDMENT; WAIVER&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;. 33<br \/>\n     Section 7.01. Termination&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 33<br \/>\n     Section 7.02. Effect of Termination&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.. 33<br \/>\n     Section 7.03. Amendment&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.. 34<br \/>\n     Section 7.04. Extension; Waiver&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 35<br \/>\n     Section 7.05. Procedure for Termination, Extension or Waiver&#8230;&#8230;&#8230;&#8230;&#8230;. 36<\/p>\n<p>ARTICLE 8  MISCELLANEOUS&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 36<br \/>\n     Section 8.01. Non-Survival of Representations and Warranties&#8230;&#8230;&#8230;&#8230;&#8230;. 36<br \/>\n     Section 8.02. Entire Agreement; Assignment&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;. 36<br \/>\n     Section 8.03. Validity&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 38<br \/>\n     Section 8.04. Notices&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;. 38<br \/>\n     Section 8.05. Governing Law&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;. 38<br \/>\n     Section 8.06. Jurisdiction&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.. 38<br \/>\n     Section 8.07. Descriptive Headings&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 38<br \/>\n     Section 8.08. Parties in Interest&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;. 38<br \/>\n     Section 8.09. Counterparts&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.. 38<br \/>\n     Section 8.10. Fees and Expenses&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 38<br \/>\n     Section 8.11. Enforcement of Agreement&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.. 39<br \/>\n     Section 8.12. Waiver of Jury Trial&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 39<br \/>\n     Section 8.13. Certain Definitions&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;. 39<br \/>\n<\/c><\/s><\/table>\n<p>                                    &#8211; ii &#8211;<\/p>\n<p>                          AGREEMENT AND PLAN OF MERGER<\/p>\n<p>          AGREEMENT AND PLAN OF MERGER (the &#8220;Agreement&#8217;), dated as of May 4,<br \/>\n2000, among Merck &amp; Co., Inc., New Jersey corporation (&#8220;Parent&#8221;), PV Acquisition<br \/>\nCorp., a Delaware corporation and an indirect wholly-owned subsidiary of Parent<br \/>\n(&#8220;Merger Subsidiary&#8221;), and ProVantage Health Services, Inc., a Delaware<br \/>\ncorporation (the &#8220;Company&#8221;).<\/p>\n<p>          WHEREAS, the Boards of Directors of Parent, Merger Subsidiary and the<br \/>\nCompany deem it advisable and in the best interests of their respective<br \/>\nstockholders that Parent acquire the Company upon the terms and subject to the<br \/>\nconditions provided for in this Agreement;<\/p>\n<p>          WHEREAS, in furtherance thereof, it is proposed that the acquisition<br \/>\nbe accomplished by Merger Subsidiary commencing a cash tender offer (as it may<br \/>\nbe amended from time to time as permitted by this Agreement, the &#8220;Offer&#8221;) to<br \/>\npurchase all of the issued and outstanding shares of common stock, par value<br \/>\n$.01 per share, of the Company (the &#8220;Common Stock&#8221;), and the associated Rights<br \/>\n(as defined in Section 4.05) (the shares of Common Stock and any associated<br \/>\nRights are referred to herein as &#8220;Shares&#8221;), for $12.25 per Share (such amount or<br \/>\nany greater amount per Share paid pursuant to the Offer being hereinafter<br \/>\nreferred to as the &#8220;Offer Price&#8221;), net to the seller in cash, upon the terms and<br \/>\nsubject to the conditions set forth in this Agreement;<\/p>\n<p>          WHEREAS, the Board of Directors of the Company has approved the Offer<br \/>\nand the Merger and resolved to recommend that holders of Shares tender their<br \/>\nShares pursuant to the Offer and approve and adopt this Agreement and the<br \/>\nMerger;<\/p>\n<p>          WHEREAS, the Boards of Directors of Parent (on its own behalf and as<br \/>\nthe sole stockholder of Merger Subsidiary), Merger Subsidiary and the Company<br \/>\nhave each approved this Agreement and the merger of Merger Subsidiary with and<br \/>\ninto the Company (the &#8220;Merger&#8221;) in accordance with the General Corporation Law<br \/>\nof the State of Delaware (the &#8220;DGCL&#8221;), in the case of each of the Company and<br \/>\nMerger Subsidiary, and in accordance with the New Jersey Business Corporation<br \/>\nAct, in the case of Parent, and upon the terms and conditions set forth in this<br \/>\nAgreement;<\/p>\n<p>          WHEREAS, Parent has required, as a condition to its willingness to<br \/>\nenter into this Agreement, that SKO Holdings, Inc., a wholly-owned subsidiary of<br \/>\nShopKo Stores, Inc. (collectively, the &#8220;Majority Stockholder&#8221;), enter into a<br \/>\nStockholder Agreement (the &#8220;Stockholder Agreement&#8221;) with Parent, substantially<br \/>\nin the form attached hereto as Exhibit A, concurrently with the execution of<br \/>\nthis Agreement;<\/p>\n<p>          WHEREAS, Parent has required, as a condition to its willingness to<br \/>\nenter into this Agreement, that the Majority Stockholder enter into a letter<br \/>\nwith the Company, providing for certain changes in their existing contractual<br \/>\narrangements upon the Majority Shareholder ceasing to own a majority of the<br \/>\noutstanding Common Stock (the &#8220;Side Letter&#8221;); and<\/p>\n<p>          WHEREAS, Parent has required, as a condition to its willingness to<br \/>\nenter into this Agreement, that Merck-Medco Managed Care, L.L.C. enter into new<br \/>\nemployment contacts (the <\/p>\n<p>                                      -1-<\/p>\n<p>&#8220;Employment Contracts&#8221;) with certain employees, providing for the terms and<br \/>\nconditions of their employment with Merck-Medco Managed Care, L.L.C. after the<br \/>\nconsummation of the Offer.<\/p>\n<p>          NOW, THEREFORE, in consideration of the representations, warranties,<br \/>\ncovenants and agreements contained in this Agreement, and intending to be<br \/>\nlegally bound hereby, Parent, Merger Subsidiary and the Company agree as<br \/>\nfollows:<\/p>\n<p>                                   ARTICLE 1<\/p>\n<p>                                     OFFER<\/p>\n<p>          Section 1.01.  The Offer.<br \/>\n                         &#8212;&#8212;&#8212; <\/p>\n<p>          (a) Within a reasonable period of time after the date of the execution<br \/>\nof this Agreement, Parent shall cause Merger Subsidiary to commence (within the<br \/>\nmeaning of Rule 14d-2 under the Securities Exchange Act of 1934, as amended (the<br \/>\n&#8220;Exchange Act&#8221;)), and Merger Subsidiary shall commence, the Offer.  Parent shall<br \/>\nuse its best efforts to cause Merger Subsidiary to commence the Offer no later<br \/>\nthan the fifth business day after the execution of this Agreement.  The<br \/>\nobligation of Merger Subsidiary to accept for payment and pay for Shares<br \/>\ntendered pursuant to the Offer shall be subject to only those conditions set<br \/>\nforth in Annex A (any of which may be waived by Merger Subsidiary in its sole<br \/>\ndiscretion; provided, however, that, without the consent of the Company, except<br \/>\nas contemplated by Section 1.01(e), Merger Subsidiary shall not waive the<br \/>\nMinimum Tender Condition (as defined in Annex A)).  Subject to the terms of the<br \/>\nOffer and this Agreement and the satisfaction or earlier waiver of all the<br \/>\nconditions of the Offer set forth in Annex A as of any expiration date of the<br \/>\nOffer, Merger Subsidiary shall accept for payment and pay for all Shares validly<br \/>\ntendered and not withdrawn pursuant to the Offer as soon as practicable after it<br \/>\nis permitted to do so under applicable law.<\/p>\n<p>          (b) As soon as practicable on the date of commencement of the Offer,<br \/>\nParent and Merger Subsidiary shall file with the Securities and Exchange<br \/>\nCommission (the &#8220;SEC&#8221;) with respect to the Offer a Tender Offer Statement on<br \/>\nSchedule TO (together with all amendments and supplements thereto, the &#8220;Schedule<br \/>\nTO&#8221;), which will comply in all material respects with the provisions of<br \/>\napplicable federal securities laws and will contain an offer to purchase<br \/>\nrelating to the Offer (the &#8220;Offer to Purchase&#8221;) and forms of related letters of<br \/>\ntransmittal and summary advertisement (which documents, together with any<br \/>\nsupplements or amendments thereto, are referred to herein collectively as the<br \/>\n&#8220;Offer Documents&#8221;).  Parent and Merger Subsidiary shall make all filings<br \/>\nrequired by applicable state law relating to the Offer (the &#8220;State Filings&#8221;) as<br \/>\nand when required by applicable state law.  Parent and Merger Subsidiary will<br \/>\ndeliver copies of the proposed forms of the Schedule TO, the Offer Documents and<br \/>\nthe State Filings (as well as any change thereto) to the Company within a<br \/>\nreasonable time prior to the commencement of the Offer for prompt review and<br \/>\ncomment by the Company and its counsel.  Parent and Merger Subsidiary will<br \/>\nprovide the Company and its counsel in writing any comments that Merger<br \/>\nSubsidiary, Parent or their counsel may receive from the SEC or its staff or any<br \/>\napplicable state authority with respect to the Offer Documents or the State<br \/>\nFilings promptly after the receipt thereof.  Parent and Merger Subsidiary shall<br \/>\npromptly correct any information in the Schedule TO, the Offer Documents or the<br \/>\nState Filings that shall have become false or misleading in any material respect<br \/>\nand take all steps necessary to cause such Schedule TO, Offer Documents or State<br \/>\nFilings as so corrected to be filed <\/p>\n<p>                                      -2-<\/p>\n<p>with the SEC and any applicable state authority and disseminated to the<br \/>\nstockholders of the Company, as and to the extent required by applicable law.<br \/>\nParent and Merger Subsidiary will provide copies of any amendments or<br \/>\nsupplements to the Offer Documents, the Schedule TO or the State Filings prior<br \/>\nto any filing of such amendments or supplements with the SEC or any applicable<br \/>\nstate authority in order to provide the Company and its counsel with a<br \/>\nreasonable opportunity to review and comment.<\/p>\n<p>          (c) Each of Parent and Merger Subsidiary expressly reserves the right<br \/>\nto modify the terms of the Offer, except that neither Parent nor Merger<br \/>\nSubsidiary shall, without the prior written consent of the Company, decrease the<br \/>\nprice per Share payable in the Offer, change the form of consideration payable<br \/>\nin the Offer, decrease the number of Shares sought pursuant to the Offer (except<br \/>\nas contemplated by Section 1.01(e)), change or modify the conditions to the<br \/>\nOffer in a manner adverse to the Company or holders of Shares, impose additional<br \/>\nconditions to the Offer, or amend any term of the Offer in any manner adverse to<br \/>\nthe Company or holders of Shares.  Notwithstanding the foregoing, Merger<br \/>\nSubsidiary, without the consent of the Company, (i) shall extend the Offer, if<br \/>\nat the then scheduled expiration date of the Offer any of the conditions to<br \/>\nMerger Subsidiary&#8217;s obligation to accept for payment and pay for Shares shall<br \/>\nnot have been satisfied, until such time as such condition is satisfied, if such<br \/>\ncondition may in the reasonable judgment of Merger Subsidiary be satisfied in a<br \/>\ntime period reasonable for such satisfaction, and (ii) may extend the Offer for<br \/>\nany period required by any rule, regulation, interpretation or position of the<br \/>\nSEC or the staff thereof applicable to the Offer.  Each extension, if any, of<br \/>\nthe Offer pursuant to clause (i) of the preceding sentence shall not exceed the<br \/>\nlesser of ten business days or such fewer number of days that Merger Subsidiary<br \/>\nreasonably believes are necessary to cause the conditions of the Offer set forth<br \/>\nin Annex A to be satisfied.  Merger Subsidiary may provide for a &#8220;subsequent<br \/>\noffering period&#8221; in accordance with Rule 14d-11 under the Exchange Act with the<br \/>\nprior consent of the Company (such consent not to be unreasonably withheld).<br \/>\nNotwithstanding the foregoing, Merger Subsidiary shall have no obligation to<br \/>\nextend the Offer if the condition to the Offer set forth in Section (c)(x) of<br \/>\nthe Annex A is not satisfied at the scheduled expiration date of the Offer.<\/p>\n<p>          (d) On or prior to the date that Merger Subsidiary becomes obligated<br \/>\nto accept for payment and pay for Shares pursuant to the Offer, Parent will<br \/>\nprovide or cause to be provided to Merger Subsidiary the funds necessary to pay<br \/>\nfor all Shares that Merger Subsidiary becomes obligated to accept for payment<br \/>\nand pay for pursuant to the Offer.<\/p>\n<p>          (e) Notwithstanding anything to the contrary in this Agreement, Merger<br \/>\nSubsidiary may waive the Minimum Tender Condition (as defined in Annex A)<br \/>\nwithout the consent of the Company as long as Merger Subsidiary is permitted by<br \/>\napplicable law to and does exercise the Option (as defined in the Stockholder<br \/>\nAgreement) immediately following the consummation of the Offer and acquires<br \/>\ntitle to all of the Shares subject thereto and thereafter promptly consummates<br \/>\nthe Merger.<\/p>\n<p>          (f) The parties hereby agree that the initial scheduled expiration<br \/>\ndate of the Offer shall be June 14, 2000.  The parties further agree that any<br \/>\nextension of the expiration date of the Offer shall result in the Offer expiring<br \/>\non the twelfth business day after the end of a Company<\/p>\n<p>                                      -3-<\/p>\n<p>Fiscal Period.  For purposes of this Agreement, Company Fiscal Period shall mean<br \/>\nany of April 29, 2000; May 27, 2000; July 1, 2000; July 29, 2000; August 26,<br \/>\n2000; September 30, 2000; October 28, 2000; November 25, 2000; or December 30,<br \/>\n2000.<\/p>\n<p>          Section 1.02.  Company Actions.<br \/>\n                         &#8212;&#8212;&#8212;&#8212;&#8212; <\/p>\n<p>          (a) The Company hereby consents to the Offer and represents that the<br \/>\nCompany&#8217;s Board of Directors, at a meeting duly called and held, has adopted<br \/>\nresolutions approving the Offer, the Merger and this Agreement, determining that<br \/>\nthe terms of the Offer and the Merger are fair to, and in the best interests of,<br \/>\nthe Company&#8217;s stockholders and recommending acceptance of the Offer and approval<br \/>\nof the Merger and this Agreement by the stockholders of the Company; provided,<br \/>\nhowever, that the Board of Directors of the Company may modify, withdraw or<br \/>\nchange such recommendation solely to the extent that the Company and the Board<br \/>\nof Directors are permitted to do so under Section 5.02 of this Agreement.<br \/>\nSubject to the foregoing and Section 5.02, the Company hereby consents to the<br \/>\ninclusion in the Offer Documents of the recommendations of the Company&#8217;s Board<br \/>\nof Directors described in this Section.<\/p>\n<p>          (b) The Company will file with the SEC on the date of the commencement<br \/>\nof the Offer a Solicitation\/Recommendation Statement on Schedule 14D-9 (together<br \/>\nwith all amendments and supplements thereto, the &#8220;Schedule 14D-9&#8221;) containing<br \/>\nsuch recommendations of the Board in favor of the Offer and the Merger;<br \/>\nprovided, however, that the Board of Directors of the Company may modify,<br \/>\nwithdraw or change such recommendation solely to the extent that the Board of<br \/>\nDirectors and the Company are permitted to do so under Section 5.02 of this<br \/>\nAgreement.  The Company will deliver the proposed forms of the Schedule 14D-9<br \/>\nand the exhibits thereto to Parent within a reasonable time prior to the<br \/>\ncommencement of the Offer for prompt review and comment by Parent and its<br \/>\ncounsel.  Parent and its counsel shall be given a reasonable opportunity to<br \/>\nreview any amendments and supplements to the Schedule 14D-9 prior to their<br \/>\nfiling with the SEC or dissemination to stockholders of the Company.  The<br \/>\nCompany will provide Parent and its counsel in writing any comments that the<br \/>\nCompany or its counsel may receive from the SEC or its staff with respect to the<br \/>\nSchedule 14D-9 promptly after receipt thereof, and shall disseminate the<br \/>\nSchedule 14D-9 as required by Rule 14d-9 promulgated under the Exchange Act.<br \/>\nThe Company shall promptly correct any information in the Schedule 14D-9 that<br \/>\nshall have become false or misleading in any material respect and take all steps<br \/>\nnecessary to cause such Schedule 14D-9 as so corrected to be filed with the SEC<br \/>\nand disseminated to the stockholders of the Company, as and to the extent<br \/>\nrequired by applicable federal securities laws.<\/p>\n<p>          (c) In connection with the Offer, the Company shall furnish to, or<br \/>\ncause to be furnished to, Parent mailing labels, security position listings and<br \/>\nany available listing or computer file containing the names and addresses of the<br \/>\nrecord holders and non-objecting beneficial owners of the Shares as of a recent<br \/>\ndate and shall furnish Parent with such information and assistance as Parent or<br \/>\nits agents may reasonably request in communicating the Offer to the stockholders<br \/>\nof the Company.  Subject to the requirements of applicable law, and except for<br \/>\nsuch steps as are necessary to disseminate the Offer Documents and any other<br \/>\ndocuments necessary to consummate the Offer or the Merger, Parent and Merger<br \/>\nSubsidiary shall, and shall cause each of their affiliates to, hold the<br \/>\ninformation contained in any of such labels and lists in confidence, use such<br \/>\ninformation only in connection with the Offer and the Merger, and, if this<br \/>\nAgreement is terminated, promptly deliver to the Company all copies of such<br \/>\ninformation, labels, listings and <\/p>\n<p>                                      -4-<\/p>\n<p>files or extracts therefrom then in their possession, in the possession of their<br \/>\nagents or representatives or under their control.<\/p>\n<p>          Section 1.03.  Directors of the Company. Promptly upon the acceptance<br \/>\n                         &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\nfor payment of and payment for any Shares by Merger Subsidiary pursuant to the<br \/>\nOffer (and, to the extent the Minimum Tender Condition is waived pursuant to<br \/>\nSection 1.01(e), the exercise of the Option as contemplated by Section 1.01(e)),<br \/>\nMerger Subsidiary shall be entitled to designate such number of directors,<br \/>\nrounded up to the next whole number, on the Board of Directors of the Company as<br \/>\nwill give Merger Subsidiary, subject to compliance with Section 14(f) of the<br \/>\nExchange Act, representation on the Board of Directors of the Company equal to<br \/>\nthe product of (a) the number of directors on the Board of Directors of the<br \/>\nCompany and (b) the percentage that such number of votes represented by Shares<br \/>\nso purchased and Shares otherwise held by Parent and its affiliates, if any,<br \/>\nbears to the number of votes represented by Shares outstanding, and the Company<br \/>\nshall at such time, subject to applicable law, cause Merger Subsidiary&#8217;s<br \/>\ndesignees to be so elected by its existing Board of Directors. Subject to<br \/>\napplicable law, the Company shall take all action requested by Parent necessary<br \/>\nto effect any such election, including mailing to its stockholders the<br \/>\ninformation statement (the &#8220;Information Statement&#8221;) containing the information<br \/>\nrequired by Section 14(f) of the Exchange Act and Rule 14(f)-1 promulgated<br \/>\nthereunder, and the Company shall make such mailing with the mailing of the<br \/>\nSchedule 14D-9 (provided that Parent and Merger Subsidiary shall have provided<br \/>\nto the Company on a timely basis all information required to be included in the<br \/>\nInformation Statement with respect to Merger Subsidiary&#8217;s designees). In<br \/>\nconnection with the foregoing, the Company will, subject to applicable law,<br \/>\npromptly either increase the size of the Board of Directors of the Company<br \/>\nand\/or obtain the resignation of such number of its current directors as is<br \/>\nnecessary to enable Merger Subsidiary&#8217;s designees to be elected or appointed to<br \/>\nthe Company&#8217;s Board of Directors as provided above; provided, however, that<br \/>\nprior to the Effective Time (as defined in Section 2.03) the Board of Directors<br \/>\nof the Company shall always have at least two (2) members who are neither<br \/>\nofficers, directors, stockholders or designees of Merger Subsidiary or any of<br \/>\nits affiliates (&#8220;Merger Subsidiary Insiders&#8221;) and each committee of the Board of<br \/>\nDirectors of the Company shall have at least one (1) member who is not a Merger<br \/>\nSubsidiary Insider. If the number of directors who are not Merger Subsidiary<br \/>\nInsiders is reduced below two (2) for any reason prior to the Effective Time,<br \/>\nthen the remaining director who is not a Merger Subsidiary Insider shall be<br \/>\nentitled to designate a person to fill such vacancy who is not a Merger<br \/>\nSubsidiary Insider and who shall be a director not deemed to be a Merger<br \/>\nSubsidiary Insider for all purposes of this Agreement. Following the election of<br \/>\nMerger Subsidiary&#8217;s designees to the Company&#8217;s Board of Directors pursuant to<br \/>\nthis Section 1.03 and prior to the Effective Time (i) any amendment or<br \/>\ntermination of this Agreement by the Company, (ii) any extension or waiver by<br \/>\nthe Company of the time for the performance of any of the obligations or other<br \/>\nacts of Parent or Merger Subsidiary under this Agreement or (iii) any waiver of<br \/>\nthe Company&#8217;s rights hereunder shall, in any such case, require the concurrence<br \/>\nof a majority of the directors of the Company then in office who are not Merger<br \/>\nSubsidiary Insiders.<\/p>\n<p>                                      -5-<\/p>\n<p>                                   ARTICLE 2<\/p>\n<p>                                   THE MERGER<\/p>\n<p>          Section 2.01.  The Merger. Upon the terms and subject to the<br \/>\n                         &#8212;&#8212;&#8212;-<br \/>\nconditions hereof, and in accordance with the relevant provisions of the DGCL,<br \/>\nMerger Subsidiary shall be merged with and into the Company as soon as<br \/>\npracticable following the satisfaction or waiver of the conditions set forth in<br \/>\nArticle 6. Following the Merger, the Company shall continue as the surviving<br \/>\ncorporation (the &#8220;Surviving Corporation&#8221;) and shall continue its existence under<br \/>\nthe laws of the State of Delaware, and the separate corporate existence of<br \/>\nMerger Subsidiary shall cease.<\/p>\n<p>          Section 2.02.  Closing. The closing of the Merger (the &#8220;Closing&#8221;) will<br \/>\n                         &#8212;&#8212;-<br \/>\ntake place at 9:00 a.m. on a date to be specified by the parties, which shall be<br \/>\nno later than the second business day after satisfaction or waiver of the<br \/>\nconditions set forth in Article 6, unless another time or date, or both, are<br \/>\nagreed to in writing by the parties hereto. The Closing will be held at the<br \/>\noffices of Foley &amp; Lardner, 777 East Wisconsin Avenue, Milwaukee, Wisconsin,<br \/>\nunless another place is agreed to by the parties.<\/p>\n<p>          Section 2.03.  Effective Time. Upon the terms and subject to the<br \/>\n                         &#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\nconditions hereof, as soon as possible after consummation of the Offer and, to<br \/>\nthe extent required by the DGCL, after the vote of the stockholders of the<br \/>\nCompany in favor of the approval of the Merger and this Agreement has been<br \/>\nobtained, the Merger shall be consummated by filing with the Secretary of State<br \/>\nof the State of Delaware, as provided in the DGCL, a certificate of merger or<br \/>\nother appropriate documents (in any such case, the &#8220;Certificate of Merger&#8221;) and<br \/>\nthe parties hereto shall make all other filings or recordings required under the<br \/>\nDGCL (the later of the time of such filing or the time specified in the<br \/>\nCertificate of Merger being the &#8220;Effective Time&#8221;).<\/p>\n<p>          Section 2.04.  Effects of the Merger. The Merger shall have the<br \/>\n                         &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\neffects set forth in Section 259 of the DGCL. As of the Effective Time, the<br \/>\nCompany, as the Surviving Corporation, shall be a wholly-owned subsidiary of<br \/>\nParent.<\/p>\n<p>          Section 2.05.  Certificate of Incorporation and Bylaws.<br \/>\n                         &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212; <\/p>\n<p>          (a) The certificate of incorporation of Merger Subsidiary in effect<br \/>\nimmediately prior to the Effective Time shall be the certificate of<br \/>\nincorporation of the Surviving Corporation (the &#8220;Charter&#8221;) from and after the<br \/>\nEffective Time; provided, however, that Article FIRST of the Charter shall be<br \/>\namended to provide that the name of the Surviving Corporation shall be the name<br \/>\nof the Company and as so amended shall be the Charter until amended in<br \/>\naccordance with applicable law and this Agreement.<\/p>\n<p>          (b) The bylaws of Merger Subsidiary in effect at the Effective Time<br \/>\nshall be the bylaws of the Surviving Corporation from and after the Effective<br \/>\nTime until amended in accordance with applicable law and this Agreement.<\/p>\n<p>          Section 2.06.  Directors and Officers. The directors of Merger<br \/>\n                         &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\nSubsidiary and the officers of the Company immediately prior to the Effective<br \/>\nTime shall be the directors and<\/p>\n<p>                                      -6-<\/p>\n<p>officers of the Surviving Corporation until their respective successors are duly<br \/>\nelected and qualified.<\/p>\n<p>          Section 2.07.  Conversion of Shares. At the Effective Time, by virtue<br \/>\n                         &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\nof the Merger and without any action on the part of Parent, Merger Subsidiary,<br \/>\nthe Company or the holders of any of the following securities:<\/p>\n<p>          (a) each Share held by the Company as treasury stock and each issued<br \/>\nand outstanding Share owned by Parent, Merger Subsidiary or any other subsidiary<br \/>\nof Parent shall be cancelled and retired and no payment made with respect<br \/>\nthereto;<\/p>\n<p>          (b) each issued and outstanding Share, other than those Shares<br \/>\nreferred to in Section 2.07(a) or Dissenting Shares (as defined in Section<br \/>\n2.08), shall be converted into the right to receive from the Surviving<br \/>\nCorporation an amount of cash equal to the Offer Price (the &#8220;Merger<br \/>\nConsideration&#8221;); and<\/p>\n<p>          (c) each share of common stock of Merger Subsidiary issued and<br \/>\noutstanding immediately prior to the Effective Time shall be converted into one<br \/>\nshare of common stock of the Surviving Corporation.<\/p>\n<p>          Section 2.08.  Dissenting Shares. Notwithstanding anything in this<br \/>\n                         &#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\nAgreement to the contrary, any issued and outstanding Shares held by a Person (a<br \/>\n&#8220;Dissenting Stockholder&#8221;) who does not vote in favor of the Merger and complies<br \/>\nwith all the provisions of Delaware law concerning the right of holders of<br \/>\nShares to require appraisal of their Shares (&#8220;Dissenting Shares&#8221;) shall not be<br \/>\nconverted as described in Section 2.07(b), but shall become the right to receive<br \/>\nsuch consideration as may be determined to be due to such Dissenting Stockholder<br \/>\npursuant to the laws of the State of Delaware. If, after the Effective Time,<br \/>\nsuch Dissenting Stockholder withdraws its demand for appraisal or fails to<br \/>\nperfect or otherwise loses such Dissenting Stockholder&#8217;s right of appraisal, in<br \/>\nany case pursuant to the DGCL, such Dissenting Stockholder&#8217;s Shares shall be<br \/>\ndeemed to be converted as of the Effective Time into the right to receive the<br \/>\nMerger Consideration. The Company shall give Parent (a) prompt notice of any<br \/>\ndemands for appraisal of Shares received by the Company and (b) the opportunity<br \/>\nto participate in and direct all negotiations and proceedings with respect to<br \/>\nany such demands. The Company shall not, without the prior written consent of<br \/>\nParent, make any payment with respect to, or settle, offer to settle or<br \/>\notherwise negotiate, any such demands.<\/p>\n<p>          Section 2.09.  Payments for Shares.<br \/>\n                         &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;- <\/p>\n<p>          (a) Prior to the commencement of the Offer, Parent shall appoint a<br \/>\ncommercial bank or trust company reasonably acceptable to the Company to act as<br \/>\nexchange agent for the Offer and the Merger (the &#8220;Exchange Agent&#8221;).  Parent will<br \/>\nenter into an exchange agent agreement with the Exchange Agent, in form and<br \/>\nsubstance reasonably acceptable to the Company, and shall deposit or cause to be<br \/>\ndeposited with the Exchange Agent in trust for the benefit of the Company&#8217;s<br \/>\nstockholders cash at such times as shall be necessary to make the payments<br \/>\npursuant to the Offer and Section 2.07 to holders of Shares (such amounts being<br \/>\nhereinafter referred to as the &#8220;Exchange Fund&#8221;).  The Exchange Agent shall,<br \/>\npursuant to irrevocable instructions, make the payments provided for in the<br \/>\npreceding sentence out of the Exchange Fund.<\/p>\n<p>                                      -7-<\/p>\n<p>          (b) Promptly after the Effective Time, Parent and the Surviving<br \/>\nCorporation shall cause the Exchange Agent to mail to each record holder, as of<br \/>\nthe Effective Time, of an outstanding certificate or certificates that<br \/>\nimmediately prior to the Effective Time represented Shares (the &#8220;Certificates&#8221;)<br \/>\na form of letter of transmittal (which shall specify that delivery shall be<br \/>\neffected, and risk of loss and title to the Certificates shall pass, only upon<br \/>\nproper delivery of the Certificates to the Exchange Agent) and instructions for<br \/>\nuse in effecting the surrender of the Certificate or payment therefor.  Upon<br \/>\nsurrender to the Exchange Agent of a Certificate, together with such letter of<br \/>\ntransmittal duly executed, the holder of such Certificate shall be paid in<br \/>\nexchange therefor cash in an amount equal to the product of the number of Shares<br \/>\nrepresented by such Certificate multiplied by the Merger Consideration, less any<br \/>\napplicable withholding taxes, and such Certificate shall forthwith be cancelled.<br \/>\nNo interest will be paid or accrued on the cash payable upon the surrender of<br \/>\nthe Certificates.  If payment is to be made to a Person other than the Person in<br \/>\nwhose name the Certificate surrendered is registered, it shall be a condition of<br \/>\npayment that the Certificate so surrendered be properly endorsed or otherwise in<br \/>\nproper form for transfer and that the Person requesting such payment pay any<br \/>\ntransfer or other taxes required by reason of the payment to a Person other than<br \/>\nthe registered holder of the Certificate surrendered or established to the<br \/>\nsatisfaction of the Surviving Corporation that such tax has been paid or is not<br \/>\napplicable.  Until surrendered in accordance with the provisions of this Section<br \/>\n2.09, each Certificate (other than Certificates representing Shares owned by<br \/>\nParent, Merger Subsidiary or any other subsidiary of Parent or Dissenting<br \/>\nShares) shall represent for all purposes only the right to receive the Merger<br \/>\nConsideration in cash multiplied by the number of Shares evidenced by such<br \/>\nCertificate, without any interest thereon.<\/p>\n<p>          (c) After the Effective Time, there shall be no further registration<br \/>\nof transfers of Shares.  If, after the Effective Time, Certificates are<br \/>\npresented to the Surviving Corporation, they shall be cancelled and exchanged<br \/>\nfor cash as provided in this Section 2.09.<\/p>\n<p>          (d) Any portion of the Exchange Fund (including the proceeds of any<br \/>\ninvestments thereof) that remains unclaimed by the stockholders of the Company<br \/>\nfor twelve months after the Effective Time shall be repaid to the Surviving<br \/>\nCorporation.  Any stockholders of the Company who have not theretofore complied<br \/>\nwith this Section 2.09 shall thereafter look only to Parent and the Surviving<br \/>\nCorporation for payment of their claim for the Merger Consideration per Share,<br \/>\nwithout any interest thereon.<\/p>\n<p>          (e) To the fullest extent permitted by applicable law, none of Parent,<br \/>\nMerger Subsidiary, the Company or the Exchange Agent shall be liable to any<br \/>\nPerson in respect of any cash delivered to a public official pursuant to any<br \/>\napplicable abandoned property, escheat or similar law.<\/p>\n<p>          (f) In the event that, subsequent to the date of this Agreement but<br \/>\nprior to the Effective Time, the outstanding Shares shall have been changed into<br \/>\na different number of Shares or a different class as a result of a stock split,<br \/>\nreverse stock split, stock dividend, subdivision, reclassification, split,<br \/>\ncombination, exchange, recapitalization or other similar transaction, the Merger<br \/>\nConsideration shall be appropriately adjusted.<\/p>\n<p>                                      -8-<\/p>\n<p>          Section 2.10.  Stock Option and Other Plans.<br \/>\n                         &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;- <\/p>\n<p>          (a) Effective as of the Effective Time, Parent shall assume each<br \/>\noutstanding option to acquire Common Stock (each, a &#8220;Company Option&#8221;), under any<br \/>\nstock option or similar plan of the Company (each, a &#8220;Stock Plan&#8221;) in accordance<br \/>\nwith this Section 2.10 and with the terms of the Stock Plan under which such<br \/>\nCompany Option was granted and the stock option agreement by which such Company<br \/>\nOption is evidenced.  Parent acknowledges and agrees that each Company Option,<br \/>\nto the extent currently not exercisable, will become exercisable in accordance<br \/>\nwith its terms upon the acceptance for payment of and payment for the Shares by<br \/>\nMerger Subsidiary pursuant to the Offer and, if applicable, the exercise of the<br \/>\nOption as contemplated by Section 1.01(e).  The proceeds from the exercise of<br \/>\nany Company Option shall be excluded from the calculation of Company Net Working<br \/>\nCapital.<\/p>\n<p>          (b) Effective as of the Effective Time, each Company Option shall be<br \/>\ndeemed to constitute an option (a &#8220;New Parent Option&#8221;) to purchase, on the same<br \/>\nterms and conditions as were applicable to such Company Option, the number of<br \/>\nshares of Parent common stock (rounded to the nearest whole number) equal to the<br \/>\nproduct of (A) and (B), where (A) is the number of shares of Common Stock<br \/>\nsubject to such Company Option and (B) is the Offer Price divided by the average<br \/>\nof the closing sales prices of Parent common stock on the New York Stock<br \/>\nExchange for the ten (10) consecutive days immediately prior to and including<br \/>\nthe day preceding the Effective Time, at an exercise price per share of Parent<br \/>\ncommon stock (rounded to the nearest whole cent) equal to (x) divided by (y),<br \/>\nwhere (x) is the aggregate exercise price for the shares of Common Stock subject<br \/>\nto such Company Option and (y) is the aggregate number of shares of Parent<br \/>\ncommon stock purchasable pursuant to the New Parent Option (as calculated<br \/>\nimmediately above); provided, however, that in the case of any Company Option to<br \/>\nwhich Section 422 of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;),<br \/>\napplies, the option price, the number of shares purchasable pursuant to such<br \/>\noption and the terms and conditions of exercise of such option shall be<br \/>\ndetermined in accordance with the foregoing, subject to such adjustments as are<br \/>\nnecessary in order to satisfy the requirements of Section 424(a) of the Code.<br \/>\nAt or prior to the Effective Time, the Company shall take all necessary actions<br \/>\nto permit the assumption of the unexercised Company Options by Parent pursuant<br \/>\nto this Section.  Section 2.10(b) of the Company Disclosure Schedule sets forth<br \/>\ntwo examples of the calculations contemplated by this paragraph.<\/p>\n<p>          (c) Not later than twenty-one calendar days after the Effective Time,<br \/>\nParent shall file a registration statement under the Securities Act of 1933, as<br \/>\namended (the &#8220;Securities Act&#8221;) on Form S-8 or other appropriate form covering<br \/>\nshares of Parent common stock subject to issuance upon the exercise of the New<br \/>\nParent Options.<\/p>\n<p>          (d) All Stock Plans shall terminate as of the Effective Time and the<br \/>\nCompany shall use commercially reasonable efforts to ensure that following the<br \/>\nEffective Time no holder of a Company Option or any participant in any Stock<br \/>\nPlans shall have any right thereunder to acquire any capital stock of the<br \/>\nCompany or any Subsidiary or the Surviving Corporation.<\/p>\n<p>                                      -9-<\/p>\n<p>                                   ARTICLE 3<\/p>\n<p>         REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUBSIDIARY<\/p>\n<p>          Except as set forth in the disclosure schedule of Parent and Merger<br \/>\nSubsidiary hereto (the &#8220;Parent Disclosure Schedule&#8221;), Parent and Merger<br \/>\nSubsidiary represent and warrant to the Company as follows:<\/p>\n<p>          Section 3.01.  Corporate Existence and Power. Each of Parent and<br \/>\n                         &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\nMerger Subsidiary is a corporation duly organized, validly existing and in good<br \/>\nstanding under the laws of the jurisdiction of its incorporation and has the<br \/>\nrequisite corporate power to carry on its business as it is now being conducted.<br \/>\nEach of Parent and Merger Subsidiary is duly qualified to do business as a<br \/>\nforeign corporation, and is in good standing in each jurisdiction where the<br \/>\ncharacter of its properties owned or leased or the nature of its activities<br \/>\nmakes such qualification necessary, except for those jurisdictions where the<br \/>\nfailure to be so qualified would not or reasonably be expected to materially<br \/>\ndelay or materially impair the ability of Parent or Merger Subsidiary to perform<br \/>\ntheir obligations under this Agreement or to consummate the transactions<br \/>\ncontemplated by this Agreement (a &#8220;Parent Material Adverse Effect&#8221;). Merger<br \/>\nSubsidiary is a wholly-owned subsidiary of Parent.<\/p>\n<p>          Section 3.02.  Corporate Authority. Each of Parent and Merger<br \/>\n                         &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\nSubsidiary has the requisite corporate power and authority to execute and<br \/>\ndeliver this Agreement and the Stockholder Agreement and to consummate the<br \/>\ntransactions contemplated hereby and thereby. The execution and delivery by<br \/>\nParent and Merger Subsidiary of this Agreement and the Stockholder Agreement,<br \/>\nand the consummation by Parent and Merger Subsidiary of the transactions<br \/>\ncontemplated hereby and thereby, have been duly authorized by their respective<br \/>\nBoard of Directors and the sole stockholder of Merger Subsidiary, and no other<br \/>\ncorporate action on the part of Parent or Merger Subsidiary is necessary to<br \/>\nauthorize the execution and delivery of this Agreement and the Stockholder<br \/>\nAgreement and the consummation by each of Parent and Merger Subsidiary of the<br \/>\ntransactions contemplated hereby (including the Offer) and thereby. Each of this<br \/>\nAgreement and the Stockholder Agreement has been duly executed and delivered by<br \/>\neach of Parent and Merger Subsidiary and constitutes a valid and binding<br \/>\nagreement of each of Parent and Merger Subsidiary, enforceable against each of<br \/>\nParent and Merger Subsidiary in accordance with its terms except as<br \/>\nenforceability may be limited by bankruptcy, insolvency, reorganization,<br \/>\nmoratorium and other similar laws affecting creditors&#8217; rights generally.<\/p>\n<p>                                      -10-<\/p>\n<p>     Section 3.03. Governmental Authorization. No consent, approval, order or<br \/>\n                   &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\nauthorization of, or registration, declaration or filing with, any federal,<br \/>\nstate or local government or any court, administrative or regulatory agency or<br \/>\ncommission or other governmental authority or agency, domestic or foreign (a<br \/>\n&#8220;Governmental Entity&#8221;) is required by Parent or Merger Subsidiary in connection<br \/>\nwith the execution and delivery of this Agreement and the Stockholder Agreement<br \/>\nby Parent or Merger Subsidiary or the consummation by Parent and Merger<br \/>\nSubsidiary of the transactions contemplated by this Agreement and the<br \/>\nStockholder Agreement, except for (a) the filing of a premerger notification and<br \/>\nreport form by Parent under the Hart-Scott-Rodino Antitrust Improvements Act of<br \/>\n1976, as amended (the &#8220;HSR Act&#8221;); (b) requirements under the Exchange Act; (c)<br \/>\nthe filing of the Certificate of Merger pursuant to the DGCL and appropriate<br \/>\ndocuments with the relevant authorities of other states in which Parent or any<br \/>\nof its subsidiaries is qualified to do business; and (d) such other consents,<br \/>\napprovals, orders, authorizations, registrations, declarations and filings the<br \/>\nfailure of which to be obtained or made would not, individually or in the<br \/>\naggregate, have or reasonably be expected to have a Parent Material Adverse<br \/>\nEffect.<\/p>\n<p>          Section 3.04.  Non-contravention. The execution, delivery and<br \/>\n                         &#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\nperformance by Parent and Merger Subsidiary of this Agreement and the<br \/>\nStockholder Agreement and the consummation by Parent and Merger Subsidiary of<br \/>\nthe transactions contemplated hereby and thereby do not and will not (with or<br \/>\nwithout notice, lapse of time or both) (a) contravene or conflict with the<br \/>\ncertificate of incorporation or bylaws or other equivalent organizational<br \/>\ndocument, in each case as amended, of Parent or any of its subsidiaries; (b)<br \/>\nassuming compliance with the matters referred to in Section 3.03, contravene or<br \/>\nconflict with or constitute a violation of any provision of any federal, state,<br \/>\nforeign or local law, regulation, judgment, injunction, order or decree binding<br \/>\nupon or applicable to Parent or any of its subsidiaries; (c) constitute a<br \/>\ndefault under or give rise to a right of termination, cancellation or<br \/>\nacceleration of any obligation of Parent or any of its subsidiaries or require<br \/>\nconsent of any third party or to a loss of a material benefit to which Parent or<br \/>\nany of its subsidiaries is entitled under any provision of any agreement,<br \/>\ncontract or other instrument binding upon Parent or any of its subsidiaries or<br \/>\nany license, franchise, permit or other similar authorization held by Parent or<br \/>\nany of its subsidiaries; or (d) result in the creation or imposition of any Lien<br \/>\non any asset of Parent or any of its subsidiaries, other than, in the case of<br \/>\nclauses (b), (c) and (d), any such conflict violation, default, right, loss or<br \/>\nLien that, individually or in the aggregate, would not reasonably be expected to<br \/>\nhave a Parent Material Adverse Effect.<\/p>\n<p>          Section 3.05.  Offer Documents; Proxy Statement; Schedule 14D-9.<br \/>\n                         &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212; <\/p>\n<p>None of the Offer Documents, the Schedule TO or the State Filings nor any<br \/>\ninformation supplied by Parent or Merger Subsidiary for inclusion in the<br \/>\nSchedule 14D-9 will, at the time the Offer Documents, the Schedule TO, the State<br \/>\nFilings, the Schedule 14D-9 or any amendments or supplements thereto, are filed<br \/>\nwith the SEC or any applicable state authority or are first published, sent or<br \/>\ngiven to stockholders of the Company, as the case may be, contain any untrue<br \/>\nstatement of a material fact or omit to state any material fact required to be<br \/>\nstated therein or necessary in order to make the statements made therein, in the<br \/>\nlight of the circumstances under which they are made, not misleading.  The<br \/>\ninformation supplied by Parent and Merger Subsidiary for inclusion in the letter<br \/>\nto stockholders, notice of meeting, proxy statement and form of proxy, or the<br \/>\ninformation statement, as the case may be, to be distributed to stockholders in<br \/>\nconnection with the Merger, or any schedule required to be filed with the SEC in<br \/>\nconnection therewith (collectively, the &#8220;Proxy Statement&#8221;), will not, on the<br \/>\ndate the Proxy Statement (or any amendment or supplement thereto) <\/p>\n<p>                                      -11-<\/p>\n<p>is first mailed to stockholders of the Company, contain any untrue statement of<br \/>\na material fact or omit to state any material fact required to be stated therein<br \/>\nor necessary in order to make the statements therein, in the light of the<br \/>\ncircumstances under which they are made, not misleading, or shall, at the time<br \/>\nof the meeting of the Company&#8217;s stockholders (the &#8220;Company Stockholder<br \/>\nMeeting&#8221;), omit to state any material fact necessary to correct any statement in<br \/>\nany earlier communication with respect to the solicitation of proxies for the<br \/>\nCompany Stockholder Meeting which shall have become false or misleading.<br \/>\nNotwithstanding the foregoing, Parent and Merger Subsidiary make no<br \/>\nrepresentation or warranty with respect to any information supplied by or on<br \/>\nbehalf of the Company which is contained in any of the Offer Documents, the<br \/>\nSchedule TO, the State Filings, the Proxy Statement or any amendment or<br \/>\nsupplement thereto. The Offer Documents and the Schedule TO shall comply as to<br \/>\nform in all material respects with the requirements of the Exchange Act and the<br \/>\nrules and regulations thereunder.<\/p>\n<p>          Section 3.06.  Financing. At each of (a) the time that Merger<br \/>\n                         &#8212;&#8212;&#8212;<br \/>\nSubsidiary becomes obligated to accept for payment and pay for Shares pursuant<br \/>\nto the Offer and, if applicable, the exercise of the Option and (b) the<br \/>\nEffective Time, Parent will have, and will make available to Merger Subsidiary,<br \/>\nthe funds necessary to consummate the Offer and, if applicable, the exercise of<br \/>\nthe Option and the Merger and the transactions contemplated thereby, and to pay<br \/>\nrelated fees and expenses.<\/p>\n<p>          Section 3.07.  Finders&#8217; Fees. Except for J. P. Morgan &amp; Co., whose<br \/>\n                         &#8212;&#8212;&#8212;&#8212;-<br \/>\nfees will be paid by Parent, there is no investment banker, broker, finder or<br \/>\nother intermediary who might be entitled to any fee or commission in connection<br \/>\nwith the transactions contemplated by this Agreement based upon arrangements<br \/>\nmade by or on behalf of Parent or Merger Subsidiary.<\/p>\n<p>          Section 3.08.  Delaware Law. As of the time immediately prior to the<br \/>\n                         &#8212;&#8212;&#8212;&#8212;<br \/>\nexecution of this Agreement, neither Parent nor any of its subsidiaries was an<br \/>\n&#8220;interested stockholder&#8221; as such term is defined in Section 203 of the DGCL.<\/p>\n<p>                                   ARTICLE 4<\/p>\n<p>                 REPRESENTATIONS AND WARRANTIES OF THE COMPANY<\/p>\n<p>          Except as set forth in the disclosure schedule of the Company hereto<br \/>\n(the &#8220;Company Disclosure Schedule&#8221;), the Company hereby represents and warrants<br \/>\nto Parent and Merger Subsidiary as follows:<\/p>\n<p>          Section 4.01.  Corporate Existence and Power. The Company is a<br \/>\n                         &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\ncorporation duly organized, validly existing and in good standing under the laws<br \/>\nof the Stare of Delaware, and has the requisite corporate power to carry on its<br \/>\nbusiness as it is now being conducted. The Company is duly qualified to do<br \/>\nbusiness as a foreign corporation and is in good standing in each jurisdiction<br \/>\nwhere the character of the property owned or leased by it or the nature of its<br \/>\nactivities makes such qualification necessary, except for those jurisdictions<br \/>\nwhere the failure to be so qualified would not have or reasonably be expected to<br \/>\nhave a material adverse effect on the <\/p>\n<p>                                      -12-<\/p>\n<p>financial condition, assets (including intangible assets), liabilities<br \/>\n(contingent or otherwise), business or results of operations of the Company and<br \/>\nits Subsidiaries taken as a whole, or materially delay or materially impair the<br \/>\nability of the Company to perform its obligations under this Agreement or to<br \/>\nconsummate the transactions contemplated by this Agreement (a &#8220;Company Material<br \/>\nAdverse Effect&#8221;). For purposes of this Agreement, any payments made by the<br \/>\nMajority Stockholder or its affiliates pursuant to Section 5.13 of this<br \/>\nAgreement shall be ignored in determining whether there has been or is<br \/>\nreasonably likely to be a Company Material Adverse Effect. The Company has<br \/>\nheretofore delivered to Parent true and complete copies of the Company&#8217;s<br \/>\ncertificate of incorporation and bylaws as currently in effect.<\/p>\n<p>          Section 4.02.  Corporate Authority. The Company has the requisite<br \/>\n                         &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\ncorporate power and authority to execute and deliver this Agreement and, subject<br \/>\nto any required approval of the Merger by the Company&#8217;s stockholders, to<br \/>\nconsummate the transactions contemplated hereby. The execution and delivery by<br \/>\nthe Company of this Agreement, and the consummation by the Company of the<br \/>\ntransactions contemplated hereby, have been duly authorized by its Board of<br \/>\nDirectors, and except for any required approval of the Merger by the Company&#8217;s<br \/>\nstockholders, no other corporate action on the part of the Company is necessary<br \/>\nto authorize the execution and delivery of this Agreement by the Company and the<br \/>\nconsummation by it of the transactions contemplated hereby. This Agreement has<br \/>\nbeen duly executed and delivered by the Company and constitutes a valid and<br \/>\nbinding agreement of the Company, enforceable against the Company in accordance<br \/>\nwith its terms except as enforceability may be limited by bankruptcy,<br \/>\ninsolvency, reorganization, moratorium and other similar laws affecting<br \/>\ncreditors&#8217; rights generally.<\/p>\n<p>          Section 4.03.  Governmental Authorization. No consent, approval, order<br \/>\n                         &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\nor authorization of or registration, declaration or filing with, any<br \/>\nGovernmental Entity is required by the Company or any Subsidiary in connection<br \/>\nwith the execution and delivery of this Agreement by the Company or the<br \/>\nconsummation by the Company of the transactions contemplated by this Agreement,<br \/>\nexcept for (a) the filing of a premerger notification and report form by the<br \/>\nCompany under the HSR Act; (b) requirements under the Exchange Act; (c) the<br \/>\nfiling of the Certificate of Merger pursuant to the DGCL and appropriate<br \/>\ndocuments with the relevant authorities of other states in which the Company is<br \/>\nqualified to do business; and (d) such other consents, approvals, orders,<br \/>\nauthorizations, registrations, declarations and filings the failure of which to<br \/>\nbe obtained or made would not, individually or in the aggregate, reasonably be<br \/>\nexpected to have a Company Material Adverse Effect.<\/p>\n<p>          Section 4.04.  Non-contravention. The execution, delivery and<br \/>\n                         &#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\nperformance by the Company of this Agreement and the consummation by the Company<br \/>\nof the transactions contemplated hereby do not and will not (with or without<br \/>\nnotice, lapse of time or both) (a) contravene or conflict with the certificate<br \/>\nof incorporation or bylaws of the Company or the comparable charter or<br \/>\norganizational documents of any Subsidiary; (b) assuming compliance with the<br \/>\nmatters referred to in Section 4.03, contravene or conflict with or constitute a<br \/>\nviolation of any provision of any federal, state, foreign or local law,<br \/>\nregulation, judgment, injunction, order or decree binding upon or applicable to<br \/>\nthe Company or any Subsidiary; (c) constitute a default under or give rise to a<br \/>\nright of termination, cancellation or acceleration of any obligation of the<br \/>\nCompany or any Subsidiary or require consent of any third party or to a loss of<br \/>\na material benefit to which the Company or any Subsidiary is entitled under any<br \/>\nprovision of any agreement, contract or other instrument binding upon the<br \/>\nCompany or any Subsidiary or any license, franchise, permit or other <\/p>\n<p>                                      -13-<\/p>\n<p>similar authorization held by the Company or any Subsidiary; or (d) result in<br \/>\nthe creation or imposition of any Lien on any asset of the Company or any<br \/>\nSubsidiary, other than, in the case of clauses (b), (c) and (d), any such<br \/>\nconflict, violation, default, right, loss or Lien that, individually or in the<br \/>\naggregate, would not reasonably be expected to have a Company Material Adverse<br \/>\nEffect.<\/p>\n<p>          Section 4.05.  Capitalization. The authorized capital stock of the<br \/>\n                         &#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\nCompany consists of 50,000,000 shares of Common Stock and 5,000,000 shares of<br \/>\nPreferred Stock, par value $.01 per share (the &#8220;Preferred Stock&#8221;), of which<br \/>\n100,000 shares have been designated as Series B Junior Participating Preferred<br \/>\nStock and reserved for issuance in connection with the Rights Agreement, dated<br \/>\nas of March 12, 1999, between the Company and Norwest Bank Minnesota, National<br \/>\nAssociation (the &#8220;Rights Agreement&#8221;). As of the date hereof, there were<br \/>\noutstanding 18,150,000 shares of Common Stock, no shares of Preferred Stock and<br \/>\nStock Options to purchase an aggregate of 873,309 Shares (none of which were<br \/>\nexercisable). All outstanding shares of capital stock of the Company have been<br \/>\nduly authorized and validly issued and are fully paid and non-assessable (except<br \/>\nfor certain statutory liabilities that may be imposed by Section 180.0622(2)(b)<br \/>\nof the Wisconsin Business Corporation Law (the &#8220;WBCL&#8221;) for unpaid employee<br \/>\nwages). Except as set forth in this Section and except for the Company&#8217;s<br \/>\nobligations under the Rights Agreement (including with respect to the preferred<br \/>\nshare purchase rights issued thereunder (the &#8220;Rights&#8221;)), there are outstanding<br \/>\n(a) no shares of capital stock or other voting securities of the Company, (b) no<br \/>\nsecurities of the Company convertible into or exchangeable for shares of capital<br \/>\nstock or voting securities of the Company, and (c) no preemptive rights, options<br \/>\nor other rights to acquire from the Company, and no obligation of the Company to<br \/>\nissue, any capital stock, voting securities or securities convertible into or<br \/>\nexchangeable for capital stock or voting securities of the Company (the<br \/>\nsecurities in clauses (a), (b) and (c) being referred to collectively as the<br \/>\n&#8220;Company Securities&#8221;). There are no outstanding (i) stock appreciation rights or<br \/>\nphantom stock units or (ii) obligations of the Company or any Subsidiary to<br \/>\nrepurchase, redeem or otherwise acquire any Company Securities. The Company and<br \/>\nits Subsidiaries do not have any bonds, debentures, notes or other obligations<br \/>\noutstanding that would give the holders of which the right to vote (or<br \/>\nconvertible into or exercisable for securities having the right to vote) with<br \/>\nthe stockholders of the Company on any matter (&#8220;Voting Debt&#8221;). No Shares,<br \/>\nPreferred Stock or other securities of the Company, the Surviving Corporation,<br \/>\nParent or any of their respective affiliates will be subject to issuance<br \/>\npursuant to the Rights Agreement as a result of the Offer, the Merger or the<br \/>\nother transactions contemplated by this Agreement and the Stockholder Agreement<br \/>\nand no Distribution Date (as such term is defined in the Rights Agreement) shall<br \/>\nhave occurred as a result of the Offer, the Merger or the other transactions<br \/>\ncontemplated by this Agreement or the Stockholder Agreement.<\/p>\n<p>          Section 4.06. Subsidiaries. The Company Disclosure Schedule sets forth<br \/>\n                        &#8212;&#8212;&#8212;&#8212;<br \/>\na list of each material Subsidiary of the Company. Each Subsidiary of the<br \/>\nCompany is a corporation or limited liability company duly incorporated or<br \/>\norganized, as the case may be, validly existing and in good standing under the<br \/>\nlaws of its jurisdiction of incorporation or organization, has all requisite<br \/>\npower and authority to carry on its business as now conducted and is duly<br \/>\nqualified to do business as a foreign corporation or foreign limited liability<br \/>\ncompany and is in good standing in each jurisdiction where the character of the<br \/>\nproperty owned or leased by it or the nature of its activities makes such<br \/>\nqualification necessary, except for those jurisdictions where failure to be so<br \/>\nqualified would not have a Company Material Adverse Effect. All of the<br \/>\noutstanding shares of capital stock or other ownership interests in each of the<br \/>\nSubsidiaries have been validly issued, and are fully <\/p>\n<p>                                      -14-<\/p>\n<p>paid, non-assessable (except for certain statutory liabilities that may be<br \/>\nimposed by Section 180.0622(2)(b) of the WBCL for unpaid employee wages) and are<br \/>\nowned by the Company or another Subsidiary free and clear of all Liens.<\/p>\n<p>          Section 4.07.  Company SEC Documents and Financial Statements.<br \/>\n                         &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\nSince July 14, 1999, the Company has filed all required forms, reports,<br \/>\nregistration statements, information statements and documents with the SEC<br \/>\nrequired to be filed by it pursuant to the federal securities laws and the SEC<br \/>\nrules and regulations thereunder (collectively, the &#8220;Company SEC Documents&#8221;),<br \/>\nall of which have complied as of their respective filing dates in all material<br \/>\nrespects with all applicable requirements of the Securities Act, and the<br \/>\nExchange Act, and the rules promulgated thereunder in effect as of the date of<br \/>\nfiling.  None of the Company SEC Documents required by the Exchange Act at the<br \/>\ntime filed, nor any of the Company SEC Documents required by the Securities Act<br \/>\nas of the date of their effectiveness, contained any untrue statement of a<br \/>\nmaterial fact or omitted to state a material fact required to be stated therein<br \/>\nor necessary in order to make the statements therein, in light of the<br \/>\ncircumstances under which they were made, not misleading, except to the extent<br \/>\nthat information contained in any Company SEC Document has been revised or<br \/>\nsuperseded by a later-filed Company SEC Document filed and publicly available<br \/>\nprior to the date hereof.  The financial statements of the Company included in<br \/>\nthe Company SEC Documents comply as to form in all material respects with<br \/>\napplicable accounting requirements and the published rules and regulations of<br \/>\nthe SEC with respect thereto, have been prepared in accordance with generally<br \/>\naccepted accounting principles (except, in the case of unaudited statements, as<br \/>\npermitted by Form l0-Q of the SEC) applied on a consistent basis during the<br \/>\nperiods involved (except as may be indicated in the notes thereto) and fairly<br \/>\npresent the consolidated financial position of the Company and its consolidated<br \/>\nSubsidiaries as of the dates thereof and the consolidated results of their<br \/>\noperations, retained earnings, changes in financial position and cash flows for<br \/>\nthe periods then ended (subject, in the case of unaudited statements, to normal<br \/>\nyear-end audit adjustments).  Except for (a) liabilities incurred in the<br \/>\nordinary course of business since January 29, 2000, (b) liabilities accrued or<br \/>\nreserved against in the Company SEC Documents, or (c) liabilities disclosed<br \/>\nherein or in the Company Disclosure Schedule, the Company does not have any<br \/>\nliabilities (whether, direct, indirect, accrued or contingent), except for such<br \/>\nliabilities, individually or in the aggregate, that would not have a Company<br \/>\nMaterial Adverse Effect.<\/p>\n<p>          Section 4.08.  Schedule 14D-9; Offer Documents; and Proxy Statement.<br \/>\n                         &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;- <\/p>\n<p>Neither the Schedule 14D-9 nor any information supplied by the Company for<br \/>\ninclusion in the Offer Documents, the Schedule TO or the State Filings will, at<br \/>\nthe respective times the Schedule 14D-9, the Offer Documents, the Schedule TO,<br \/>\nthe State Filings or any amendments or supplements thereto are filed with the<br \/>\nSEC or any applicable state authority are first published, sent or given to<br \/>\nstockholders of the Company, as the case may be, contain any untrue statement of<br \/>\na material fact or omit to state any material fact required to be stated therein<br \/>\nor necessary in order to make the statements made therein, in the light of the<br \/>\ncircumstances under which they are made, not misleading.  The Proxy Statement<br \/>\nwill not, on the date the Proxy Statement (or any amendment or supplement<br \/>\nthereto) is first mailed to the stockholders of the Company, contain any untrue<br \/>\nstatement of a material fact, or omit to state any material fact required to be<br \/>\nstated therein or necessary in order to make the statements made therein, in the<br \/>\nlight of the circumstances under which they are made, not misleading or will, at<br \/>\nthe time of the Company Stockholder Meeting, omit to state any material fact<br \/>\nnecessary to correct any statement in any earlier communication with respect to<br \/>\nthe solicitation of proxies for the Company Stockholder Meeting which shall be<br \/>\nbecome <\/p>\n<p>                                      -15-<\/p>\n<p>false or misleading in any material respect. The Schedule 14D-9 and the Proxy<br \/>\nStatement will, when filed by the Company with the SEC, comply as to form in all<br \/>\nmaterial respects with the applicable provisions of the Exchange Act and the<br \/>\nrules and regulations thereunder. Notwithstanding the foregoing, the Company<br \/>\nmakes no representation or warranty with respect to information supplied by or<br \/>\non behalf of Parent or Merger Subsidiary which is contained in any of the<br \/>\nforegoing documents.<\/p>\n<p>          Section 4.09.  Absence of Certain Changes. Except as disclosed in the<br \/>\n                         &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\nCompany SEC Documents or as contemplated by this Agreement, since January 29,<br \/>\n2000, there has not been any event, occurrence or development that has had or<br \/>\nwould be reasonably likely to result in a Company Material Adverse Effect,<br \/>\nexcept for general economic changes or changes that affect the industry of the<br \/>\nCompany or any Subsidiary generally (collectively, &#8220;General Changes&#8221;) and<br \/>\nchanges in the Company&#8217;s business after the date hereof attributable primarily<br \/>\nto actions taken by Parent or Merger Subsidiary, which shall include without<br \/>\nlimitation any disruptions to the business of the Company and its Subsidiaries<br \/>\nprimarily as a result of the execution of this Agreement or the announcement of<br \/>\nthe transactions contemplated by this Agreement (collectively, the &#8220;Transaction<br \/>\nChanges&#8221;). Except as disclosed in the Company SEC Documents, since January 29,<br \/>\n2000, there has not been (a) any declaration, setting aside or payment of any<br \/>\ndividend or other distribution in respect of the capital stock of the Company or<br \/>\nany redemption or other acquisition by the Company of any Shares, (b) any split,<br \/>\ncombination, or reclassification of the Company&#8217;s capital stock or any issuance<br \/>\nor the authorization of any issuance of any other securities in respect of, in<br \/>\nlieu of or in substitution for shares of its capital stock, (c) any granting by<br \/>\nthe Company or any of the Subsidiaries to any officer or key employee of the<br \/>\nCompany or any of the Subsidiaries of any increase in compensation, except in<br \/>\nthe ordinary course of business consistent with past practice or as was required<br \/>\nunder employment agreements in effect as of the date of the most recent<br \/>\nfinancial statements included in the Company SEC Documents, (d) any entry by the<br \/>\nCompany or any Subsidiary into any employment, severance or termination<br \/>\nagreement with any such officer or key employee or granting by the Company or<br \/>\nany Subsidiary to any such officer or key employee of any increase in severance<br \/>\nor termination pay, except as was required under employment, severance or<br \/>\ntermination agreements in effect as of the date of the most recent financial<br \/>\nstatements included in the Company SEC Documents, (e) any damage, destruction or<br \/>\nloss, whether or not covered by insurance, that has or would be reasonably<br \/>\nlikely to have a Company Material Adverse Effect or (f) any change in accounting<br \/>\nmethods, principles or practices by the Company or any Subsidiary materially<br \/>\naffecting its assets, liabilities or business, except insofar as may have been<br \/>\nrequired by a change in generally accepted accounting principles.<\/p>\n<p>          Section 4.10.  Litigation. Except as disclosed in the Company SEC<br \/>\n                         &#8212;&#8212;&#8212;-<br \/>\nDocuments, as of the date hereof, there is no civil, criminal, administrative or<br \/>\nregulatory action, suit, claim, investigation or proceeding pending or, to the<br \/>\nknowledge of the Company, threatened against the Company or any Subsidiary<br \/>\nbefore any court or arbitrator or before or by any governmental body, agency or<br \/>\nofficial that would have or be reasonably likely to have a Company Material<br \/>\nAdverse Effect.<\/p>\n<p>          Section 4.11.  Proprietary Rights. The Company and its Subsidiaries<br \/>\n                         &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\npossess or have adequate rights to use all material trademarks, service marks,<br \/>\nbrand marks, brand names, trade names, trade dress, domain names, inventions<br \/>\n(whether patentable or unpatentable), patents, databases, computer software and<br \/>\nrelated documents and data, and copyrights, and all applications <\/p>\n<p>                                      -16-<\/p>\n<p>and registrations therefor (collectively, the &#8220;Proprietary Rights&#8221;), necessary<br \/>\nfor the operation of the businesses of each of the Company and its Subsidiaries<br \/>\nas currently conducted free and clear of all Liens with such exceptions as would<br \/>\nnot have a Company Material Adverse Effect. The use of such Proprietary Rights<br \/>\nby the Company or its Subsidiaries does not conflict with, infringe upon or<br \/>\nviolate the Proprietary Rights of any other Person, except where such conflict,<br \/>\ninfringement or violation would not have a Company Material Adverse Effect. The<br \/>\nCompany has received no written notice that the use of any Proprietary Rights by<br \/>\nthe Company or its Subsidiaries conflicts with, infringes upon or violates any<br \/>\nProprietary Rights of any other Person. Neither the Company nor any of its<br \/>\nSubsidiaries is in default under the terms of any third party license or other<br \/>\nright to use any Proprietary Rights, except where such default would not have a<br \/>\nCompany Material Adverse Effect. To the Company&#8217;s knowledge, no third party has<br \/>\ninfringed upon, violated or otherwise come into conflict with the Proprietary<br \/>\nRights possessed or used by the Company or its Subsidiaries, except where such<br \/>\nconflict, infringement or violation would not have a Company Material Adverse<br \/>\nEffect.<\/p>\n<p>          Section 4.12.  Benefit Plans; ERISA.<br \/>\n                         &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211; <\/p>\n<p>          (a) The Company Disclosure Schedule sets forth a complete list of all<br \/>\n&#8220;employee benefit plans&#8221; (as defined in Section 3(3) of the Employee Retirement<br \/>\nIncome Security Act of 1974, as amended (&#8220;ERISA&#8221;)), bonus, pension, profit<br \/>\nsharing, deferred compensation, incentive compensation, excess benefit, stock,<br \/>\nstock option, severance, termination pay, change in control or other material<br \/>\nemployee benefit plans, programs, arrangements or agreements currently<br \/>\nmaintained, or contributed to, or required to be maintained or contributed to,<br \/>\nby the Company, the Majority Stockholder or any Person that, together with the<br \/>\nCompany, is treated as a single employer under Section 414 of the Code for the<br \/>\nbenefit of any current or former employees, officers, directors or independent<br \/>\ncontractors of the Company or any Subsidiary and with respect to which the<br \/>\nCompany or any Subsidiary has any liability (collectively, the &#8220;Benefit Plans&#8221;).<br \/>\nThe Company has delivered or made available to Parent true, complete and correct<br \/>\ncopies of each Benefit Plan.<\/p>\n<p>          (b) Each Benefit Plan has been administered in accordance with its<br \/>\nterms and in compliance with the applicable provisions of ERISA, the Code and<br \/>\nother applicable law, except where the failure to so administer or comply would<br \/>\nnot have a Company Material Adverse Effect.<\/p>\n<p>          (c) All Benefit Plans intended to be qualified under Section 401(a) of<br \/>\nthe Code have been the subject of determination letters from the Internal<br \/>\nRevenue Service to the effect that such Benefit Plans are qualified and exempt<br \/>\nfrom federal income taxes under Section 401(a) and 501(a), respectively, of the<br \/>\nCode as amended at least through the statutory changes implemented under the Tax<br \/>\nReform Act of 1986, and no such determination letter has been revoked nor, to<br \/>\nthe knowledge of the Company, has revocation been threatened, nor has any such<br \/>\nBenefit Plan been amended since the date of its most recent determination letter<br \/>\nor application therefor in any respect that would adversely affect its<br \/>\nqualification.<\/p>\n<p>          (d) No Benefit Plan is subject to Title IV of ERISA or Section 412 of<br \/>\nthe Code and no Benefit Plan is a &#8220;multiemployer plan&#8221; (as defined in Section<br \/>\n3(37) of ERISA).<\/p>\n<p>                                      -17-<\/p>\n<p>          (e) No Person has incurred any material liability under Title IV of<br \/>\nERISA or Section 412 of the Code during the time such Person was required to be<br \/>\ntreated as a single employer with the Company under Section 414 of the Code that<br \/>\nwould have a Company Material Adverse Effect.<\/p>\n<p>          (f) With respect to any Benefit Plan that is an employee welfare<br \/>\nbenefit plan (as defined in Section 3(l) of ERISA), (i) no such Benefit Plan<br \/>\nprovides benefits, including without limitation, death or medical benefits,<br \/>\nbeyond termination of employment or retirement other than (A) coverage mandated<br \/>\nby law or (B) death or retirement benefits under a Benefit Plan qualified under<br \/>\nSection 401(a) of the Code, and (ii) each such Benefit Plan (including any such<br \/>\nPlan covering retirees or other former employees) may be amended or terminated<br \/>\nwithout liability that would have a Company Material Adverse Effect.<\/p>\n<p>          (g) The execution of, and performance of the transactions contemplated<br \/>\nin, this Agreement will not (either alone or upon the occurrence of any<br \/>\nadditional or subsequent events) (i) constitute an event under any Benefit Plan<br \/>\nthat will or may result in any payment (whether of severance pay or otherwise),<br \/>\nacceleration, forgiveness of indebtedness, vesting, distribution, increase in<br \/>\nbenefits or obligation to fund benefits with respect to any employee of the<br \/>\nCompany or any of its Subsidiaries, or (ii) result in the triggering or<br \/>\nimposition of any restrictions or limitations on the right of the Company or<br \/>\nParent to cause any such Benefit Plan to be amended or terminated (or which<br \/>\nwould result in any materially adverse consequence for so doing).  No payment or<br \/>\nbenefit that will or may be made by the Company, Parent, or any of their<br \/>\nrespective subsidiaries or affiliates with respect to any employee of the<br \/>\nCompany or any of its Subsidiaries under any Benefit Plan in connection with the<br \/>\nOffer and the Merger will be characterized as an &#8220;excess parachute payment,&#8221;<br \/>\nwithin the meaning of Section 280G(b)(1) of the Code.  The parties hereby agree<br \/>\nto use their commercially reasonable efforts to limit the application of Section<br \/>\n280G(b)(1) of the Code to the transactions contemplated hereby.<\/p>\n<p>          Section 4.13.  Environmental Matters. Except as set forth in the<br \/>\n                         &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\nCompany SEC Documents, to the Company&#8217;s knowledge, (a) the Company and each<br \/>\nSubsidiary is and has been in material compliance with, and has no material<br \/>\nliability under, any and all laws relating to the protection of human health or<br \/>\nthe environment (&#8220;Environmental Laws&#8221;), and (b) neither the Company nor any<br \/>\nSubsidiary is the subject of any federal, state, local or foreign investigation,<br \/>\nand neither the Company nor any Subsidiary has received any written notice or<br \/>\nclaim, or entered into any negotiations or agreements with any Person, relating<br \/>\nto any material liability or material remedial action or potential material<br \/>\nliability or material remedial action under any Environmental Laws.<\/p>\n<p>          Section 4.14.  Taxes. The Company and each of its Subsidiaries, and<br \/>\n                         &#8212;&#8211;<br \/>\nany consolidated, combined or unitary group for tax purposes of which the<br \/>\nCompany or any of its Subsidiaries is or has been a member, has timely filed,<br \/>\ntaking into account all extensions of time to file, all Tax Returns required to<br \/>\nbe filed by it in the manner provided by law, except any Tax Return with respect<br \/>\nto which no material Taxes were due. All such filed Tax Returns are true,<br \/>\ncorrect and complete in all material respects. The Company and each of its<br \/>\nSubsidiaries have timely paid all Taxes shown as due on such Tax Returns, except<br \/>\nand, for Taxes that are adequately reserved for on the Company financial<br \/>\nstatements in accordance with generally accepted accounting principles, for<br \/>\nwhich a notice of deficiency has been received. The Company and each of its<\/p>\n<p>                                      -18-<\/p>\n<p>Subsidiaries have timely withheld and paid over to the appropriate taxing<br \/>\nauthority where due all Taxes required to be withheld from amounts owing to any<br \/>\nemployee, creditor or third party. Except as set forth in the Company Disclosure<br \/>\nSchedule, (a) no claim for material unpaid Taxes has become a Lien against the<br \/>\nproperty of the Company or any of its Subsidiaries or is being asserted against<br \/>\nthe Company or any of its Subsidiaries; (b) no audit, examination, investigation<br \/>\nor other proceeding is pending, being conducted, or to the knowledge of the<br \/>\nCompany, threatened by a Tax authority in connection with any examination of<br \/>\nTaxes paid by or on behalf of, or Tax Returns filed by or on behalf of, the<br \/>\nCompany and its Subsidiaries; (c) no extension or waiver of the statute of<br \/>\nlimitations on the assessment of any Taxes has been granted by the Company or<br \/>\nany of its Subsidiaries and is currently in effect; (d) neither the Company nor<br \/>\nany of its Subsidiaries is a party to, is bound by, or has any obligation under,<br \/>\nor potential liability with regards to, any Tax sharing agreement, Tax<br \/>\nindemnification agreement or similar contract or arrangement and neither the<br \/>\nCompany nor any Subsidiary has any liability for Taxes under Treasury Regulation<br \/>\nSection 1.1502-6 (or an analogous provision of state, local or foreign law),<br \/>\nother than Taxes of the Company and its Subsidiaries; (e) no power of attorney<br \/>\nhas been granted by or with respect to the Company or any of its Subsidiaries<br \/>\nwith respect to any matter relating to Taxes; (f) neither the Company nor any of<br \/>\nits Subsidiaries has any material deferred intercompany gain or loss arising as<br \/>\na result of a deferred intercompany transaction within the meaning of Treasury<br \/>\nRegulation Section 1.1502-13 (or similar provision under state, local or foreign<br \/>\nlaw) or any excess loss accounts within the meaning of Treasury Regulation<br \/>\nSection 1.1502-19; and (g) neither the Company nor any of its Subsidiaries has<br \/>\nbeen the subject of a Tax ruling or determination that has continuing effect.<\/p>\n<p>          Section 4.15.  Certain Approvals. Except for Chapter 552 of the WBCL<br \/>\n                         &#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\nand Section 203 of the DGCL, no &#8220;fair price,&#8221; &#8220;moratorium,&#8221; &#8220;control share<br \/>\nacquisition&#8221; or other similar antitakeover statute or regulation (&#8220;Antitakeover<br \/>\nStatutes&#8221;) is applicable to the Company, the Shares, the Offer, the Merger, this<br \/>\nAgreement, the Stockholder Agreement or the transactions hereby or thereby. The<br \/>\nBoard of Directors of the Company has approved the Offer, the Merger and the<br \/>\nother transactions contemplated by this Agreement in accordance with the<br \/>\nprovisions of Section 203 of the DGCL.<\/p>\n<p>          Section 4.16.  Opinion of Financial Advisor. The Board of Directors of<br \/>\n                         &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\nthe Company has received the opinion of Merrill Lynch, Pierce, Fenner &amp; Smith<br \/>\nIncorporated (&#8220;Merrill Lynch&#8221;), dated the date of this Agreement, to the effect<br \/>\nthat the consideration to be received by the holders of Shares pursuant to this<br \/>\nAgreement is fair to such stockholders from a financial point of view.<\/p>\n<p>          Section 4.17.  Rights Plan. The Board of Directors of the Company has<br \/>\n                         &#8212;&#8212;&#8212;&#8211;<br \/>\nirrevocably and unconditionally amended the Rights Agreement to provide that so<br \/>\nlong as this Agreement has not been terminated pursuant to Section 7.01, a<br \/>\nDistribution Date (as such term is defined in the Rights Agreement) shall not<br \/>\noccur or be deemed to occur, and neither Parent nor Merger Subsidiary shall<br \/>\nbecome an Acquiring Person (as such term is defined in the Rights Agreement), as<br \/>\na result of the execution, delivery or performance of this Agreement, the<br \/>\nannouncement, making or consummation of the Offer, the acquisition of the Shares<br \/>\npursuant to the Offer or the Merger, the consummation of the Merger or any other<br \/>\ntransaction contemplated by this Agreement.<\/p>\n<p>                                      -19-<\/p>\n<p>          Section 4.18.  Fees and Commissions. Other than fees payable to<br \/>\n                         &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\nMerrill Lynch, no Person is entitled to receive from the Company or any<br \/>\nSubsidiary any investment banking, brokerage or finder&#8217;s fee or commissions in<br \/>\nconnection with this Agreement or the transactions contemplated hereby. Parent<br \/>\nhas been provided with a true and correct copy of the Merrill Lynch engagement<br \/>\nletter.<\/p>\n<p>          Section 4.19.  Compliance; Permits. Neither the Company nor any of its<br \/>\n                         &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\nSubsidiaries is in default or violation of any federal, state, foreign or local<br \/>\nlaw, regulation, judgment, injunction, order or decree binding or applicable to<br \/>\nthe Company or any of its Subsidiaries or by which its or any of their<br \/>\nrespective properties are bound or affected (except, in each case, with respect<br \/>\nto environmental matters, which are governed by Section 4.13), except, with<br \/>\nrespect to laws and regulations, for any such defaults or violations that,<br \/>\nindividually or in the aggregate, would not have or reasonably be expected to<br \/>\nhave a Company Material Adverse Effect. Each of the Company and its Subsidiaries<br \/>\nis in possession of all franchises, grants, authorizations, licenses, permits,<br \/>\neasements, variances, exemptions, consents, certificates, approvals and orders<br \/>\nnecessary to own, lease and operate its and their respective properties and to<br \/>\ncarry on its and their respective businesses as such are now being conducted<br \/>\n(collectively, the &#8220;Company Permits&#8221;), except where the failure to possess such<br \/>\nCompany Permits, individually or in the aggregate, would not have a Company<br \/>\nMaterial Adverse Effect.<\/p>\n<p>          Section 4.20.  Contracts. (a) Each contract that is material to the<br \/>\n                         &#8212;&#8212;&#8212;-<br \/>\nbusiness of the Company and the Subsidiaries (a &#8220;Company Material Contract&#8221;) is<br \/>\nin full force and effect, other than as would not have, individually or in the<br \/>\naggregate, a Company Material Adverse Effect. Neither the Company nor any<br \/>\nSubsidiary, nor, to the knowledge of the Company, any other party, is in default<br \/>\nunder any Company Material Contract, except for such defaults which would not<br \/>\nhave, individually or in the aggregate, a Company Material Adverse Effect and,<br \/>\nto the knowledge of the Company, no event has occurred which, with the passage<br \/>\nof time or the giving of notice or both, would constitute such a default.<\/p>\n<p>          (b) During the twelve months immediately prior to the date hereof, no<br \/>\nSignificant Customer (as defined below) has cancelled or otherwise terminated or<br \/>\nthreatened in writing to terminate its relationship with the Company or its<br \/>\nSubsidiaries.  For purposes of this Section 4.20 &#8220;Significant Customer&#8221; means<br \/>\nany customer of the Company&#8217;s pharmacy management business that, individually or<br \/>\nin the aggregate, accounted for 10.0% or more of the consolidated revenues of<br \/>\nthe Company during the fiscal year ended January 29, 2000.<\/p>\n<p>          Section 4.21.  Affiliate Transactions.<br \/>\n                         &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;- <\/p>\n<p>          (a) The Company Disclosure Schedule sets forth a complete and correct<br \/>\nlist as of the date hereof of (A) all written contracts and agreements to which<br \/>\nthe Company or any of its Subsidiaries, on the one hand, and the Majority<br \/>\nStockholder or any of its affiliates (other than the Company or its<br \/>\nSubsidiaries), on the other hand, are a party that are in effect as of the date<br \/>\nhereof and (B) all material non-cash and non-cash equivalent assets, properties<br \/>\nand services of the Company or its Subsidiaries used by the Majority Stockholder<br \/>\nor any of its affiliates (other than the Company or its Subsidiaries) at any<br \/>\ntime since January 29, 2000.<\/p>\n<p>                                      -20-<\/p>\n<p>          (b) The Company Disclosure Schedule sets forth (i) a description of<br \/>\nall intercompany payables or receivables (whether long term or short term, all<br \/>\nof which will be deemed short term for purposes of this Agreement) as of the<br \/>\ndate hereof between the Majority Stockholder and its affiliates (other than the<br \/>\nCompany and its Subsidiaries), on the one hand, and the Company and its<br \/>\nSubsidiaries, on the other hand, and (ii) the net amount of such intercompany<br \/>\npayables and\/or receivables (the &#8220;Intercompany Balance&#8221;) as of April 1, 2000.<\/p>\n<p>          Section 4.22.  Working Capital. The Company Disclosure Schedule sets<br \/>\n                         &#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\nforth the amount of Company Net Working Capital as of April 1, 2000. For<br \/>\npurposes of this Agreement, &#8220;Company Net Working Capital&#8221; shall mean current<br \/>\nassets less current liabilities. Current assets include without limitation cash<br \/>\nand cash equivalents, receivables (less allowance for losses), pharmaceutical<br \/>\ninventories, deferred tax benefits and other current assets. Current liabilities<br \/>\ninclude without limitation short-term debt, accounts payable, accrued<br \/>\nliabilities and all intercompany amounts due to and\/or from the Majority<br \/>\nStockholder and its affiliates other than the Company (whether short term or<br \/>\nlong term). Except as expressly required to the contrary by this definition, the<br \/>\naccounting policies that are used in the definition of Company Net Working<br \/>\nCapital shall be consistent with those applied to the financial statements of<br \/>\nthe Company as of and for the year ended January 29, 2000 (the &#8220;January 29, 2000<br \/>\nFinancial Statements&#8221;). Company Net Working Capital on any particular date shall<br \/>\nbe calculated as if such date were the Company&#8217;s normal year-end.<\/p>\n<p>                                   ARTICLE 5<\/p>\n<p>                                   COVENANTS<\/p>\n<p>          Section 5.01.  Conduct of Business of the Company. Except as<br \/>\n                         &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\ncontemplated by this Agreement or as approved in writing by Parent, during the<br \/>\nperiod from the date of this Agreement to the Effective Time (unless (i) Parent,<br \/>\nas controlling shareholder, directs the Company to the contrary or (ii) Parent&#8217;s<br \/>\ndesignees on the Company&#8217;s Board of Directors vote in favor of a contrary<br \/>\naction), the Company and the Subsidiaries will each conduct its operations<br \/>\naccording to its ordinary and usual course of business and, to the extent<br \/>\nconsistent therewith, will use their respective commercially reasonable efforts<br \/>\nto preserve its business organization substantially intact and substantially<br \/>\nmaintain its existing relations and goodwill with customers, suppliers,<br \/>\ndistributors, creditors, lessors, employees and business associates. Without<br \/>\nlimiting the generality of the foregoing, and except as otherwise expressly<br \/>\nprovided in this Agreement, neither the Company nor any Subsidiary, without the<br \/>\nprior written consent of Parent, will:<\/p>\n<p>          (a) issue, sell or pledge, or authorize or propose the issuance, sale<br \/>\nor pledge of (i) additional shares of capital stock of any class (including the<br \/>\nShares), or securities convertible into any such shares, or any rights, warrants<br \/>\nor options to acquire any such shares or other convertible securities, or grant<br \/>\nor accelerate any right to convert or exchange any securities of the Company for<br \/>\nshares, other than (A) Shares issuable pursuant to the terms of outstanding<br \/>\nCompany Options and commitments disclosed in Section 4.05, or (B) the issuance<br \/>\nof shares of capital stock to the Company by a wholly-owned Subsidiary, or (ii)<br \/>\nany other securities in respect of, in lieu of or in substitution for Shares<br \/>\noutstanding on the date thereof or split, combine or reclassify any of the<br \/>\nCompany&#8217;s capital stock or (iii) any Voting Debt or any other property or<br \/>\nassets;<\/p>\n<p>                                      -21-<\/p>\n<p>          (b) purchase, redeem or otherwise acquire, or propose to purchase or<br \/>\notherwise acquire, any of its outstanding securities (including the Shares)<br \/>\nother than pursuant to the Stock Plans;<\/p>\n<p>          (c) declare, set aside or pay any dividend or other distribution on<br \/>\nany shares of capital stock of the Company, except that a direct or indirect<br \/>\nwholly-owned Subsidiary may pay a dividend or distribution to its parent;<\/p>\n<p>          (d) make (i) any acquisition of a material amount of assets or<br \/>\nsecurities, any disposition (including by way of any Lien) of a material amount<br \/>\nof assets or securities, or enter into a material contract or release or<br \/>\nrelinquish any material contract rights, or make any amendments, or<br \/>\nmodifications thereto, except in all instances for actions in the ordinary<br \/>\ncourse of business, or (ii) for the initial ninety days after the date hereof,<br \/>\nany individual capital expenditures in excess of $350,000 and $3.0 million in<br \/>\nthe aggregate; provided, however, if the Offer has not been consummated within<br \/>\nninety days of the date hereof, the parties will negotiate in good faith to<br \/>\nestablish a reasonable capital expenditure budget.<\/p>\n<p>          (e) except in the ordinary course of business, (i) incur any<br \/>\nindebtedness for borrowed money or guarantee any such indebtedness of another<br \/>\nPerson or (ii) make any loans, advances of capital contributions to, or<br \/>\ninvestments in, any other Person, other than to the Company or any direct or<br \/>\nindirect wholly-owned Subsidiary;<\/p>\n<p>          (f) propose or adopt any amendments to the certificate of<br \/>\nincorporation or bylaws of the Company;<\/p>\n<p>          (g) except as provided in Section 5.01(g) of the Company Disclosure<br \/>\nSchedule, enter into any new employment, severance or termination agreements<br \/>\nwith, or grant any increase in severance or termination pay to, any officers,<br \/>\ndirectors or key employees or grant any material increases in the compensation<br \/>\n(except in the ordinary course of business consistent with past practice) or<br \/>\nbenefits to officers, directors and key employees or adopt any new employee<br \/>\nbenefit plan, program, policy or arrangement;<\/p>\n<p>          (h) change any accounting methods, principles or practices materially<br \/>\naffecting their assets, liabilities or business, except insofar as may be<br \/>\nrequired by a change in generally accepted accounting principles;<\/p>\n<p>          (i) settle or compromise any material claims or litigation or modify,<br \/>\namend or terminate any of its material contracts or waive, release or assign any<br \/>\nmaterial rights or claims; or permit any insurance policy naming it as a<br \/>\nbeneficiary or loss-payable payee to be canceled or terminated except in the<br \/>\nordinary and usual course of business;<\/p>\n<p>          (j) make any material tax election or settle or compromise any<br \/>\nmaterial income tax liability; or<\/p>\n<p>          (k) agree in writing or otherwise to take any of the foregoing<br \/>\nactions.<\/p>\n<p>                                      -22-<\/p>\n<p>          Section 5.02.  Acquisition Proposals.<br \/>\n                         &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212; <\/p>\n<p>          The Company shall, and shall use its best efforts to cause its<br \/>\nnonstockholder affiliates and the officers, directors and employees of the<br \/>\nCompany and its Subsidiaries to, and shall instruct its stockholder affiliates<br \/>\nand the representatives and agents of the Company and its Subsidiaries<br \/>\n(including, without limitation, any investment banker, attorney or accountant<br \/>\nretained by the Company or any of its Subsidiaries) to, immediately cease and<br \/>\nterminate any existing activities, discussions or negotiations, if any, with any<br \/>\nparties (other than Parent and Merger Subsidiary, any affiliate or associate of<br \/>\nParent and Merger Subsidiary or any designees of Parent and Merger Subsidiary)<br \/>\nconducted heretofore with respect to any acquisition or exchange of all or any<br \/>\nmaterial portion of the assets of, or more than 20% of the equity interest in,<br \/>\nthe Company or any of its Subsidiaries (by direct purchase from the Company,<br \/>\ntender or exchange offer or otherwise) or any business combination, merger or<br \/>\nsimilar transaction (including an exchange of stock or assets) with or involving<br \/>\nthe Company or any Subsidiary or division of the Company (an &#8220;Acquisition<br \/>\nTransaction&#8221;), other than the Offer and the Merger. Except as set forth in this<br \/>\nSection 5.02, the Company shall not, and shall use its best efforts to cause its<br \/>\nnonstockholder affiliates and the officers, directors and employees of the<br \/>\nCompany and its Subsidiaries not to, and shall instruct its stockholder<br \/>\naffiliates and the representatives and agents of the Company and its<br \/>\nSubsidiaries (including, without limitation, any investment banker, attorney or<br \/>\naccountant retained by the Company or any of its Subsidiaries) not to, directly<br \/>\nor indirectly, knowingly encourage, solicit, participate in or initiate<br \/>\ndiscussions or negotiations with, or provide any nonpublic information or data<br \/>\n(other than the Company&#8217;s standard public information package) to, any Person or<br \/>\ngroup of Persons (other than Parent and Merger Subsidiary, any affiliate or<br \/>\nassociate of Parent and Merger Subsidiary or any designees of Parent and Merger<br \/>\nSubsidiary) with respect to any inquiries or the making of any offer or proposal<br \/>\n(including, without limitation, any offer or proposal to the stockholders of the<br \/>\nCompany) concerning an Acquisition Transaction (an &#8220;Acquisition Proposal&#8221;) or<br \/>\notherwise knowingly facilitate any effort or attempt to make or implement an<br \/>\nAcquisition Proposal; provided, however, that prior to the date of acceptance<br \/>\nfor payment of and payment for Shares by Merger Subsidiary pursuant to the<br \/>\nOffer, or, to the extent the Minimum Tender Condition is waived pursuant to<br \/>\nSection 1.01(e), the date on which the Option is exercised (the earliest of such<br \/>\ndates is referred to as the &#8220;Closing Date&#8221;), the Company may furnish information<br \/>\nand access, but only in response to a request for information or access, to any<br \/>\nPerson making a bona fide written fully-financed (which for the purposes of this<br \/>\nAgreement shall mean the receipt of a commitment letter, from a reputable Person<br \/>\ncapable of financing the transaction, subject only to normal and customary<br \/>\nexceptions) all-cash Acquisition Proposal to the board of directors of the<br \/>\nCompany after the date hereof which was not knowingly encouraged, solicited or<br \/>\ninitiated by the Company or any of its affiliates or any director, employee,<br \/>\nrepresentative or agent of the Company or any of its Subsidiaries (including,<br \/>\nwithout limitation, any investment banker, attorney or accountant retained by<br \/>\nthe Company or any of its Subsidiaries) on or after the date hereof and may<br \/>\nparticipate in discussions and negotiate with such Person concerning any such<br \/>\nbona fide written fully-financed all-cash Acquisition Proposal and the board of<br \/>\ndirectors of the Company may modify, amend or withdraw its recommendation<br \/>\nrelative to the Offer or the Merger or authorize the Company, subject to Section<br \/>\n7.02(b), to enter into a binding written agreement concerning a Superior<br \/>\nProposal (as defined below), if and only if, in any such case, (i) the board of<br \/>\ndirectors of the Company determines in good faith, (A) taking into account the<br \/>\nreasoned advice of outside counsel to the Company to the effect that failing to<br \/>\nprovide such information or access or to participate in such discussions or<br \/>\nnegotiations or so to authorize or modify, to amend or withdraw <\/p>\n<p>                                      -23-<\/p>\n<p>such recommendation, as the case may be, is more likely than not to constitute a<br \/>\nbreach of such board&#8217;s fiduciary duties under applicable law, and (B) taking<br \/>\ninto account the advice of financial advisors to the Company to such effect,<br \/>\nthat such bona fide written all-cash fully-financed Acquisition Proposal, if<br \/>\naccepted, is reasonably likely to be consummated, taking into account all<br \/>\nfinancial aspects of the proposal and the Person making the proposal and would,<br \/>\nif consummated, result in a transaction more favorable to the Company&#8217;s<br \/>\nstockholders from a financial point of view than the transaction contemplated by<br \/>\nthis Agreement (any such more favorable bona fide written fully-financed all-<br \/>\ncash Acquisition Proposal as to which both of the determinations referred to in<br \/>\nsubclauses (A) and (B) above have been made being referred to in this Agreement<br \/>\nas a &#8220;Superior Proposal&#8221;), and (ii) the board of directors of the Company<br \/>\nreceives from the Person making such bona fide written all-cash fully-financed<br \/>\nAcquisition Proposal an executed confidentiality agreement the terms of which<br \/>\nare (without regard to the terms of such Acquisition Proposal) (A) no less<br \/>\nfavorable to the Company, and (B) no less restrictive to the Person making such<br \/>\nbona fide written all-cash fully-financed Acquisition Proposal than those<br \/>\ncontained in the Confidentiality Agreement, dated as of December 28, 1999<br \/>\nreferring to Parent as the &#8220;Recipient&#8221; (the &#8220;Company Confidentiality<br \/>\nAgreement&#8221;), between the Company and Parent. The Company will notify Parent<br \/>\nwithin 48 hours if any such inquiries or proposals are received by, any such<br \/>\ninformation is requested from, or any such negotiations or discussions are<br \/>\nsought to be initiated or continued with the Company and shall in such notice<br \/>\nindicate the identity of the offeror and the material terms and conditions of<br \/>\nany such proposal and thereafter shall keep Parent reasonably informed, on a<br \/>\ncurrent basis, of the status and material terms of such proposals and the status<br \/>\nof such negotiations or discussions, providing copies to Parent of any<br \/>\nAcquisition Proposals made in writing. The Company shall provide Parent with<br \/>\nfour business days advance notice of, in each and every case, its intention to<br \/>\neither enter into any agreement with or to provide any information to any Person<br \/>\nmaking any such inquiry or proposal. Subject to the provisions of Section 5.02,<br \/>\nthe Company agrees not to release any third party from, or waive any provisions<br \/>\nof, any confidentiality or standstill agreement to which the Company is a party<br \/>\nand will use its best efforts to enforce any such agreements at the request of<br \/>\nand on behalf of Parent. The Company will inform the individuals or entities<br \/>\nreferred to in the first sentence of this Section 5.02 of the obligations<br \/>\nundertaken in this Section 5.02. The Company also will, at the request of<br \/>\nParent, promptly request each person or entity which has executed, within 12<br \/>\nmonths prior to the date of this Agreement, a confidentiality agreement in<br \/>\nconnection with its consideration of acquiring the Company to return or destroy<br \/>\nall confidential information heretofore furnished to such person or entity by or<br \/>\non behalf of the Company.<\/p>\n<p>          Section 5.03.  Access to Information.<br \/>\n                         &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212; <\/p>\n<p>          (a) Except for competitively sensitive information or as limited by<br \/>\napplicable law, between the date of this Agreement and the Effective Time, the<br \/>\nCompany will upon reasonable notice (i) give Parent and its authorized<br \/>\nrepresentatives reasonable access during regular business hours to the Company&#8217;s<br \/>\nand each Subsidiary&#8217;s offices and other facilities and to its books and records,<br \/>\n(ii) permit Parent to make such inspections as it may require and (iii) cause<br \/>\nits officers and those of the Subsidiaries to furnish Parent with such financial<br \/>\nand operating data and other information with respect to the business and<br \/>\nproperties of the Company and the Subsidiaries as Parent may from time to time<br \/>\nreasonably request (including any request related to implementation of Section<br \/>\n5.13 hereof).  Parent and Merger Subsidiary will use their commercially<br \/>\nreasonable <\/p>\n<p>                                      -24-<\/p>\n<p>efforts to minimize any disruption to the businesses of the Company and the<br \/>\nSubsidiaries that may result from the requests for data and information<br \/>\nhereunder.<\/p>\n<p>          (b) Information obtained by Parent pursuant to this Section 5.03 shall<br \/>\nbe subject to the provisions of the Company Confidentiality Agreement, which<br \/>\nremains in full force and effect.<\/p>\n<p>          Section 5.04.  Commercially Reasonable Efforts.<br \/>\n                         &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;- <\/p>\n<p>          (a) Subject to the terms and conditions of this Agreement and<br \/>\napplicable law, each of the parties shall act in good faith and use commercially<br \/>\nreasonable efforts to take, or cause to be taken, all actions, and to do, or<br \/>\ncause to be done, all things necessary, proper or advisable to consummate and<br \/>\nmake effective the transactions contemplated by this Agreement as soon as<br \/>\npracticable.  Without limiting the foregoing, the parties shall use commercially<br \/>\nreasonable efforts to (and shall use commercially reasonable efforts to cause<br \/>\ntheir respective subsidiaries, and use commercially reasonable efforts to cause<br \/>\ntheir respective affiliates, directors, officers, employees, agents, attorneys,<br \/>\naccountants and representatives, to) (i) consult and cooperate with and provide<br \/>\nassistance to each other in the preparation and filing with the SEC of the Offer<br \/>\nDocuments, the Schedule TO, the State Filings, the Schedule 14D-9 and the Proxy<br \/>\nStatement and all necessary amendments or supplements thereto; (ii) obtain all<br \/>\nconsents, approvals, waivers, licenses, permits, authorizations, registrations,<br \/>\nqualifications or other permissions or actions by, and give all necessary<br \/>\nnotices to, and make all filings with and applications and submissions to, any<br \/>\nGovernmental Entity or other Person necessary in connection with the<br \/>\nconsummation of the transactions contemplated by this Agreement as soon as<br \/>\nreasonably practicable; (iii) provide all such information concerning such<br \/>\nparty, its subsidiaries and its officers, directors, employees, partners and<br \/>\naffiliates as may be necessary or reasonably requested in connection with any of<br \/>\nthe foregoing and (iv) avoid the entry of, or have vacated or terminated, any<br \/>\ndecree, order or judgment that would restrain, prevent, or delay the<br \/>\nconsummation of the Offer or the Merger.  Prior to making any application to or<br \/>\nfiling with a Governmental Entity or other entity in connection with this<br \/>\nAgreement (other than filing under the HSR Act), each party shall provide the<br \/>\nother party with drafts thereof and afford the other party a reasonable<br \/>\nopportunity to comment on such drafts.<\/p>\n<p>          (b) Parent shall take any and all commercially reasonable steps<br \/>\nnecessary to avoid or eliminate every applicable impediment under any antitrust,<br \/>\ncompetition or trade regulation law that is asserted by any Governmental Entity<br \/>\nwith respect to the Offer or the Merger so as to enable the consummation of the<br \/>\nOffer or the Merger to occur as expeditiously as possible.  The parties agree<br \/>\nthat such commercially reasonable efforts of Parent shall include (1) the<br \/>\nobligation of Parent to litigate with any Governmental Entity for a period from<br \/>\nthe date hereof through and including December 31, 2000 and (2) the obligation<br \/>\nof Parent to divest assets or businesses of the Company as may be required in<br \/>\norder to facilitate the expiration of any applicable waiting period under any<br \/>\nantitrust, competition or trade regulation law, to secure the termination of any<br \/>\ninvestigation by any Governmental Entity or to avoid the filing of litigation by<br \/>\nany Governmental Entity seeking to enjoin the purchase of Shares pursuant to the<br \/>\nOffer or the consummation of the Merger, or to the entry of, or to effect the<br \/>\ndissolution of, any injunction, temporary restraining order or other order in<br \/>\nany suit or proceeding, which would otherwise have the effect of preventing or<br \/>\ndelaying the purchase of Shares pursuant to the Offer or the consummation of the<br \/>\nMerger; provided, however, the parties further agree that nothing in this<br \/>\n        &#8212;&#8212;&#8211;  &#8212;&#8212;-<br \/>\nsection shall require that Parent (i) <\/p>\n<p>                                      -25-<\/p>\n<p>divest, sell or hold separate any of its assets or properties other than assets<br \/>\nor properties of the Company, (ii) consent to Parent or the Company doing any of<br \/>\nthe foregoing if any proposed divestiture of assets or businesses would have or<br \/>\nbe reasonable likely to have a Company Material Adverse Effect, (iii) enter into<br \/>\na consent decree or assume any other obligations with respect to the ongoing<br \/>\noperations of Parent, its subsidiaries or the Company or (iv) litigate with any<br \/>\nGovernmental Entity for a period beyond December 31, 2000.<\/p>\n<p>          (c) Notwithstanding anything to the contrary in the foregoing<br \/>\nparagraph (b), Parent agrees that it will enter into a consent order if the sole<br \/>\npurpose of such order is to cause the Company to become subject to the existing<br \/>\nFederal Trade Commission consent order, In the Matter of Merck &amp; Co., Inc. And<br \/>\nMerck-Medco Managed Care, L.L.C., File No. 951-0097, to the same extent that<br \/>\nMerck-Medco Managed Care, L.L.C. is currently subject to such consent order.<\/p>\n<p>          (d) The Company, Parent and Merger Subsidiary shall keep the other<br \/>\nreasonably apprised of the status of matters relating to completion of the<br \/>\ntransactions contemplated hereby, including promptly furnishing the other with<br \/>\ncopies of notices or other communications received by Parent, Merger Subsidiary<br \/>\nor the Company, as the case may be, or any of their respective Subsidiaries,<br \/>\nfrom any third party and\/or any Governmental Entity with respect to the<br \/>\ntransactions contemplated by this Agreement.<\/p>\n<p>          (e) The Company shall give prompt notice to Parent of any change that<br \/>\nhas resulted in or would be reasonably likely to have a Company Material Adverse<br \/>\nEffect and Parent shall give the Company prompt notice of any change that has<br \/>\nresulted in or would be reasonably likely to have a Parent Material Adverse<br \/>\nEffect.<\/p>\n<p>          (f) If any Antitakeover Statute shall or may become applicable to the<br \/>\nOffer or the Merger or the other transactions contemplated by this Agreement or<br \/>\nthe Stockholder Agreement, each of Parent and the Company and their respective<br \/>\nBoard of Directors shall grant such approvals and take such lawful actions as<br \/>\nare necessary so that such transactions may be consummated as promptly as<br \/>\npracticable on the terms contemplated by this Agreement or the Stockholder<br \/>\nAgreement or by the Offer or the Merger and otherwise act to eliminate or<br \/>\nminimize the effects of such statute or regulation on such transactions.<\/p>\n<p>          Section 5.05.  Indemnification Exculpation and Insurance.<br \/>\n                         &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211; <\/p>\n<p>          (a) In the event of any threatened or actual claim, action, suit,<br \/>\nproceeding or investigation, whether civil, criminal or administrative,<br \/>\nincluding, without limitation, any such claim, action, suit, proceeding or<br \/>\ninvestigation in which any person who is now, or has been at any time prior to<br \/>\nthe date of this Agreement, or who becomes prior to the Effective Time, a<br \/>\ndirector, officer or employee of the Company or any of its Subsidiaries<br \/>\n(including in his or her role as a fiduciary of the employee benefit plans of<br \/>\nthe Company, if applicable) (the &#8220;Indemnified Parties&#8221;) is, or is threatened to<br \/>\nbe, made a party based in whole or in part on, or arising in whole or in part<br \/>\nout of, or pertaining to (i) the fact that he or she is or was a director,<br \/>\nofficer or employee of the Company, any of its Subsidiaries or any of their<br \/>\nrespective predecessors or (ii) this Agreement or any of the transactions<br \/>\ncontemplated hereby, whether in any case asserted or arising before or after the<br \/>\nEffective Time, the parties hereto agree to cooperate and use their commercially<br \/>\nreasonable efforts to defend against and respond thereto.  It is understood and<br \/>\nagreed that after the <\/p>\n<p>                                      -26-<\/p>\n<p>Effective Time, Parent shall indemnify and hold harmless, to the fullest extent<br \/>\npermitted by law, each such Indemnified Party against any losses, claims,<br \/>\ndamages, liabilities, costs, expenses (including reasonable attorney&#8217;s fees and<br \/>\nexpenses in advance of the final disposition of any claim, suit, proceeding or<br \/>\ninvestigation to each Indemnified Party to the fullest extent permitted by law<br \/>\nupon receipt of any undertaking required by applicable law), judgments, fines<br \/>\nand amounts paid in settlement in connection with any such threatened or actual<br \/>\nclaim, action, suit, proceeding or investigation, and in the event of any such<br \/>\nthreatened or actual claim, action, suit, proceeding or investigation (whether<br \/>\nasserted or arising before or after the Effective Time), the Indemnified Parties<br \/>\nmay retain counsel satisfactory to them after consultation with Parent;<br \/>\nprovided, however, that (A) Parent shall have the right to assume the defense<br \/>\nthereof and upon such assumption Parent shall not be liable to any Indemnified<br \/>\nParty for any legal expenses of other counsel or any other expenses subsequently<br \/>\nincurred by any Indemnified Party in connection with the defense thereof, except<br \/>\nthat if Parent elects not to assume such defense or counsel for the Indemnified<br \/>\nParties reasonably advises that there are issues which raise conflicts of<br \/>\ninterest between Parent and the Indemnified Parties, the Indemnified Parties may<br \/>\nretain counsel satisfactory to them after consultation with Parent, and Parent<br \/>\nshall pay the reasonable fees and expenses of such counsel for the Indemnified<br \/>\nParties, (B) Parent shall in all cases be obligated pursuant to this Section<br \/>\n5.05(a) to pay for only one firm of counsel for all Indemnified Parties, (C)<br \/>\nParent shall not be liable for any settlement effected without its prior written<br \/>\nconsent (which consent shall not be unreasonably withheld) and (D) Parent shall<br \/>\nhave no obligation hereunder to any Indemnified Party when and if a court of<br \/>\ncompetent jurisdiction shall ultimately determine, and such determination shall<br \/>\nhave become final and nonappealable, that indemnification of such Indemnified<br \/>\nParty in the manner contemplated hereby is prohibited by applicable law. Any<br \/>\nIndemnified Party wishing to claim indemnification under this Section 5.05(a),<br \/>\nupon learning of any such claim, action, suit, proceeding or investigation,<br \/>\nshall promptly notify Parent thereof, provided that the failure to so notify<br \/>\nshall not affect the obligations of Parent under this Section 5.05(a) except to<br \/>\nthe extent such failure to notify materially prejudices Parent. Upon written<br \/>\nrequest by an Indemnified Party, Parent shall advance all expenses incurred by<br \/>\nsuch Indemnified Party in connection with any such claim, action, suit,<br \/>\nproceeding or investigation to which such Indemnified Party is a party or is<br \/>\nentitled to indemnification pursuant to this Section 5.05(a). The right to<br \/>\nindemnification and the advancement of expenses conferred by this Section<br \/>\n5.05(a) shall not be exclusive of any other rights that any Indemnified Party<br \/>\nseeking indemnification or advancement of expenses may be entitled to or<br \/>\nhereafter acquire under any statute, agreement or provision of the Company&#8217;s or<br \/>\nthe Surviving Corporation&#8217;s certificate of incorporation or bylaws or otherwise.<br \/>\nParent&#8217;s obligations under this Section 5.05(a) shall continue in full force and<br \/>\neffect for a period of six (6) years from the Effective Time; provided, however,<br \/>\nthat all rights to indemnification in respect of any claim (a &#8220;Claim&#8221;) asserted<br \/>\nor made within such period shall continue until the final disposition of such<br \/>\nClaim.<\/p>\n<p>          (b) Without limiting the foregoing, Merger Subsidiary and Parent agree<br \/>\nthat (i) the certificate of incorporation and bylaws of the Surviving<br \/>\nCorporation shall contain the provisions with respect to indemnification and<br \/>\nlimitation of liability set forth in the Company&#8217;s certificate of incorporation<br \/>\nand bylaws on the date hereof, which provisions shall not be amended, repealed<br \/>\nor otherwise modified for a period of six (6) years after the Effective Time in<br \/>\nany manner that would adversely affect the rights thereunder of individuals who<br \/>\nat any time prior to the Effective Time were directors or officers of the<br \/>\nCompany, and (ii) all rights to indemnification and exculpation from liabilities<br \/>\nfor acts or omissions occurring at or prior to the Effective Time now <\/p>\n<p>                                      -27-<\/p>\n<p>existing in favor of the current or former directors or officers of the Company<br \/>\nand the Subsidiaries as provided in any indemnification agreements of the<br \/>\nCompany shall be assumed by the Surviving Corporation in the Merger, without<br \/>\nfurther action, as of the Effective Time and shall survive the Merger and shall<br \/>\ncontinue in full force and effect (to the extent consistent with applicable law)<br \/>\nin accordance with their terms. In the event that Parent or the Surviving<br \/>\nCorporation or any of their respective successors or assigns (A) consolidates<br \/>\nwith or merges into any other Person and is not the continuing or surviving<br \/>\ncorporation or entity of such consolidation or merger or (B) transfers or<br \/>\nconveys all or substantially all of its properties and assets to any Person,<br \/>\nthen, and in each such case, proper provision will be made so that the<br \/>\nsuccessors and assigns of Parent or the Surviving Corporation, as the case may<br \/>\nbe, assume the obligations set forth in this Section 5.05.<\/p>\n<p>          (c) For six (6) years after the Effective Time, the Surviving<br \/>\nCorporation shall provide officers&#8217; and directors&#8217; liability insurance in<br \/>\nrespect of acts or omissions occurring prior to the Effective Time, including<br \/>\nbut not limited to the transactions contemplated by this Agreement, covering<br \/>\neach person currently covered by the Company&#8217;s officers&#8217; and directors&#8217;<br \/>\nliability insurance policy, or who becomes covered by such policy prior to the<br \/>\nEffective Time, on terms with respect to coverage and amount no less favorable<br \/>\nthan those of such policy in effect on the date hereof, provided, however, that<br \/>\nin satisfying its obligation under this Section 5.05 the Surviving Corporation<br \/>\nshall not be obligated to pay annual premiums in excess of 200% of the amount<br \/>\nper annum the Company is currently paying for such coverage (the &#8220;Insurance<br \/>\nAmount&#8221;); provided further, that if the Insurance Amount is insufficient to<br \/>\nmaintain or procure the coverage contemplated by this Section 5.05(c), then the<br \/>\nSurviving Corporation shall use commercially reasonable efforts to obtain as<br \/>\nmuch comparable insurance as is available for the Insurance Amount.<\/p>\n<p>          (d) For six (6) years after the Effective Time, Parent shall cause the<br \/>\nSurviving Corporation to honor its commitments and obligations pursuant to this<br \/>\nSection 5.05.  The provisions of this Section 5.05 are (i) intended to be for<br \/>\nthe benefit of, and will be enforceable by, each indemnified party, his or her<br \/>\nheirs and his or her representatives and (ii) in addition to, and not in<br \/>\nsubstitution or, any other rights to indemnification or contribution that any<br \/>\nsuch person may have by contract or otherwise.<\/p>\n<p>          Section 5.06.  Employee Plans and Benefits and Employment Contracts.<br \/>\n                         &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;- <\/p>\n<p>          (a) From and after the Effective Time, Parent shall cause the<br \/>\nSurviving Corporation to honor in accordance with their terms all existing<br \/>\nemployment, severance, consulting or other compensation agreements, plans or<br \/>\ncontracts between the Company or any Subsidiary and any officer, director or<br \/>\nemployee of the Company or any Subsidiary set forth on Section 5.06 of the<br \/>\nCompany Disclosure Schedule.<\/p>\n<p>          (b) Parent agrees that, on and following the Effective Time, all<br \/>\nemployees of the Company and its subsidiaries as of the Effective Time (whether<br \/>\nor not on disability or leave of absence) (the &#8220;Current Employees&#8221;) shall be<br \/>\nimmediately eligible to participate in employee benefit plans and programs of<br \/>\nParent and its Affiliates on substantially the same terms and conditions as are<br \/>\napplicable to similarly situated non-bargained employees (i) with crediting of<br \/>\nprior employment with the Company and the Majority Stockholder, to the extent<br \/>\ncredited by either of them, for purposes of eligibility waiting periods and<br \/>\nvesting requirements, (ii) with recognition <\/p>\n<p>                                      -28-<\/p>\n<p>of all co-payments and deductibles so that Current Employees are not treated as<br \/>\nnew employees of Parent and its affiliates but as if they had been employees of<br \/>\nsuch entitles throughout the period that they were employed with the Company and<br \/>\nthe Majority Stockholder and (iii) without application of preexisting condition<br \/>\nand similar exclusion provisions that did not apply to the Current Employees<br \/>\nprior to the Effective Time, but, in the case of each of (i) and (ii) only to<br \/>\nthe extent that employment, co-payments and deductibles are recognized in<br \/>\nrespect of employees of Parent and its affiliates other than the Current<br \/>\nEmployees; and provided, that this Section 5.06(b) shall not apply to (x)<br \/>\n               &#8212;&#8212;&#8211;<br \/>\neligibility to receive retiree medical benefits, (y) the application of the<br \/>\ncost-sharing features applicable to such retiree medical benefits and (z)<br \/>\napplication of the provisions of all stock option programs of Parent and its<br \/>\naffiliates relating to retirement.<\/p>\n<p>          (c) The Company will take all action necessary such that, effective as<br \/>\nof the Closing Date, the Company shall cease to participate in the employee<br \/>\nbenefit plans, programs, policies and arrangements sponsored and maintained by<br \/>\nthe Majority Stockholder (collectively, the &#8220;ShopKo Plans&#8221;).<\/p>\n<p>          (d) Except as provided in Section 5.06(e), the Company shall use<br \/>\ncommercially reasonable efforts to cause the Majority Stockholder to retain,<br \/>\nbear and be responsible for all liabilities and obligations under the ShopKo<br \/>\nPlans.  Without limiting the generality of the foregoing sentence, the Company<br \/>\nshall use commercially reasonable efforts to cause the Majority Stockholder to<br \/>\nbear and be responsible for all liabilities and obligations under the ShopKo<br \/>\nStores, Inc. Deferred Compensation Plan.  Prior to the Closing Date, the Company<br \/>\nshall cause any accrued liabilities applicable to the Shopko Plans to be removed<br \/>\nfrom its and its Subsidiaries&#8217; books.<\/p>\n<p>          (e) Prior to the Closing Date, the Company shall take all action<br \/>\nnecessary such that, immediately prior to the Closing Date, all Current<br \/>\nEmployees of the Company and its subsidiaries who participate in the ShopKo<br \/>\nStores, Inc. Profit Sharing and Super Saver Plan (the &#8220;401(k) Plan&#8221;) shall<br \/>\nbecome fully vested in any unvested portion of their accounts under the 401(k)<br \/>\nPlan.  The Company shall cause the trustee of any trust in which the 401(k) Plan<br \/>\nparticipates (the &#8220;Trust&#8221;), as of the Trust&#8217;s valuation date on or next<br \/>\nfollowing the Effective Time (the &#8220;Valuation Date&#8221;), to value, in a manner<br \/>\nconsistent with its prior practice, the account balances under the 401(k) Plan<br \/>\nof the Current Employees (collectively the &#8220;Account Balances&#8221;).  As soon as<br \/>\npracticable after the determination of the Account Balances, the Company shall<br \/>\ncause the trustee of the Trust to transfer to a successor tax-qualified trust<br \/>\ndesignated by Parent an amount in cash equal to the Account Balances and<br \/>\noutstanding participant loans, if any (i) increased by interest during the<br \/>\nperiod from the Valuation Date to the date of transfer (the &#8220;Interim Period&#8221;) at<br \/>\nan interest rate equal to the interest rate credited on short-term investments<br \/>\nheld in the Trust (the &#8220;Short-Term Rate&#8221;) and (ii) reduced by benefit payments<br \/>\nto employees or their beneficiaries made in accordance with the provisions of<br \/>\nthe 401(k) Plan during the Interim Period plus interest on such benefit payments<br \/>\nat the Short-Term Rate from the date of payment until the transfer date.<\/p>\n<p>          Section 5.07.  Meeting of the Company&#8217;s Stockholders.<br \/>\n                         &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;- <\/p>\n<p>          (a) After consummation of the Offer, to the extent required by<br \/>\napplicable law, the Company shall promptly take all action necessary in<br \/>\naccordance with the DGCL and the Company&#8217;s certificate of incorporation and<br \/>\nbylaws to convene the Company Stockholder Meeting to consider and vote on the<br \/>\nMerger and this Agreement.  At the Company Stockholder Meeting, all <\/p>\n<p>                                      -29-<\/p>\n<p>of the Shares then owned by Parent, Merger Subsidiary or any other subsidiary of<br \/>\nParent shall be voted to approve the Merger and this Agreement. Subject to<br \/>\nSection 5.02, the Board of Directors of the Company shall recommend that the<br \/>\nCompany&#8217;s stockholders vote to approve the Merger and this Agreement if such<br \/>\nvote is sought, shall use commercially reasonable efforts to solicit from<br \/>\nstockholders of the Company proxies in favor of the Merger and shall take all<br \/>\nother reasonable action in its judgment necessary and appropriate to secure the<br \/>\nvote of stockholders required by the DGCL to effect the Merger.<\/p>\n<p>          (b) If required under applicable law, the Company and Parent shall<br \/>\nprepare the Proxy Statement, file it with the SEC under the Exchange Act as<br \/>\npromptly as practicable after Merger Subsidiary purchases Shares pursuant to the<br \/>\nOffer, and use all reasonable efforts to have it cleared by the SEC.  As<br \/>\npromptly as practicable after the Proxy Statement has been cleared by the SEC,<br \/>\nthe Company shall mail the Proxy Statement to the stockholders of the Company as<br \/>\nof the record date for the Company Stockholder Meeting.<\/p>\n<p>          (c) Parent and Merger Subsidiary shall not, and they shall cause their<br \/>\nsubsidiaries not to, sell, transfer, assign, encumber or otherwise dispose of<br \/>\nthe Shares acquired pursuant to the Offer or otherwise prior to the Company<br \/>\nStockholder Meeting; provided, however, that this Section 5.07(c) shall not<br \/>\napply to the sale, transfer, assignment, encumbrance or other disposition of any<br \/>\nor all such Shares in transactions involving solely Parent, Merger Subsidiary<br \/>\nand\/or one or more of their wholly-owned subsidiaries.<\/p>\n<p>          (d) Notwithstanding the foregoing, in the event that Merger Subsidiary<br \/>\nshall acquire Shares representing at least 90% of the votes represented by all<br \/>\noutstanding Common Stock, the parties hereto agree, at the request of Merger<br \/>\nSubsidiary, to take all necessary and appropriate action to cause the Merger to<br \/>\nbecome effective, in accordance with Section 253 of the DGCL, as soon as<br \/>\nreasonably practicable after such acquisition, without a meeting of the<br \/>\nstockholders of the Company.<\/p>\n<p>          Section 5.08.  De-registration. The Company shall use commercially<br \/>\n                         &#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\nreasonable efforts to cause the Shares to be de-registered from the New York<br \/>\nStock Exchange and de-registered under the Exchange Act as soon as practicable<br \/>\nfollowing the Effective Time.<\/p>\n<p>          Section 5.09.  Certain Actions. The Company shall settle the<br \/>\n                         &#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\nIntercompany Balance and terminate all ongoing contracts, commitments and<br \/>\narrangements between the Majority Stockholder and its affiliates (other than the<br \/>\nCompany or its Subsidiaries) and the Company and its Subsidiaries (including,<br \/>\nwithout limitation, those listed on the Company Disclosure Schedule) as of the<br \/>\nacceptance for payment of and payment for any Shares by Merger Subsidiary<br \/>\npursuant to the Offer, except for transactions contemplated by this Agreement<br \/>\nand the following agreements as contemplated by the Side Letter: (a)<br \/>\nIndemnification and Hold Harmless Agreement dated July 19, 1999, which shall<br \/>\nremain in full force and effect after the Change of Control Date (as defined in<br \/>\nthe Side Letter); (b) Tax Sharing Agreement dated July 19, 1999, which shall<br \/>\nremain in full force and effect after the Change of Control Date (as defined in<br \/>\nthe Side Letter); (c) Prescription Benefit Management Agreement dated March 4,<br \/>\n1996, which shall be amended as of the Change of Control Date (as defined in the<br \/>\nSide Letter); (d) Lease Agreement dated August 1, 1999, which shall be amended<br \/>\nas of the Change of Control Date (as defined in the Side Letter); (e)<br \/>\nInformation Technology Services Agreement dated July 19, 1999, which shall be<br \/>\namended as of the Change of <\/p>\n<p>                                      -30-<\/p>\n<p>Control Date (as defined in the Side Letter) and (f) End User License Agreement<br \/>\ndated as of January 29, 2000, which shall be amended as of the Change of Control<br \/>\nDate (as defined in the Side Letter) (collectively, the &#8220;Affiliate Agreements&#8221;).<\/p>\n<p>          Section 5.10.  Affiliate Transactions. Except as contemplated by this<br \/>\n                         &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\nAgreement or the Side Letter or as approved in writing by Parent, after the date<br \/>\nof this Agreement to the consummation of the Offer, the Company:<\/p>\n<p>          (a) will not terminate, amend, modify, or grant any waivers of the<br \/>\nAffiliate Agreements or the Employment Contracts in any respects; or<\/p>\n<p>          (b) will not permit the Intercompany Balance to be increased or<br \/>\ndecreased other than as a result of cash advances or payments required to be<br \/>\nmade in the ordinary course of business pursuant to the terms of the agreements<br \/>\nlisted in the Company Disclosure Schedule.<\/p>\n<p>          Section 5.11.  Public Announcements. Parent and the Company shall<br \/>\n                         &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\nconsult with each other before issuing, and provide each other the opportunity<br \/>\nto review, comment upon and concur with, any press release or other public<br \/>\nstatement with respect to the transactions contemplated by this Agreement,<br \/>\nincluding the Offer and the Merger, and shall not issue any such press release<br \/>\nor make any such public statement prior to such consultation, except as either<br \/>\nparty may determine is required by applicable law or by obligations pursuant to<br \/>\nany listing agreement with any national securities exchange.<\/p>\n<p>          Section 5.12.  Performance by Merger Subsidiary. Parent hereby agrees<br \/>\n                         &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\nto cause Merger Subsidiary to comply with its obligations hereunder and under<br \/>\nthe Offer and to cause Merger Subsidiary to consummate the Merger as<br \/>\ncontemplated herein.<\/p>\n<p>          Section 5.13. Working Capital.<br \/>\n                        &#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\n          (a) The Company will, within five business days after the end of each<br \/>\nCompany Fiscal Period (including, without limitation, the Company Fiscal Period<br \/>\nimmediately prior to the scheduled expiration date of the Offer), deliver to<br \/>\nParent a certificate providing the Company&#8217;s good faith calculation of Company<br \/>\nNet Working Capital on a line-item by line-item basis at the end of such<br \/>\nimmediately prior Company Fiscal Period.<\/p>\n<p>          (b) Parent shall cause Arthur Andersen L.L.P. (&#8220;Arthur Andersen&#8221;) to,<br \/>\nwithin five business days of receipt by Parent of the certificate of the Company<br \/>\ncontemplated by paragraph (a) of this Section 5.13 with regard to the Company<br \/>\nFiscal Period immediately prior to expiration of the Offer, deliver to the<br \/>\nCompany and the Majority Stockholder Arthur Andersen&#8217;s calculation of Company<br \/>\nNet Working Capital on a line-item by line-item basis for such Company Fiscal<br \/>\nPeriod.<\/p>\n<p>          (c) If Arthur Andersen&#8217;s calculation of Company Net Working Capital<br \/>\ndiscloses that Company Net Working Capital is less than $55.0 million (a<br \/>\n&#8220;Working Capital Shortfall&#8221;), the Majority Stockholder may within one business<br \/>\nday, in its sole discretion, make a payment to Parent in the amount of the<br \/>\nWorking Capital Shortfall by immediately available funds.  If the Majority<br \/>\nStockholder timely makes such a payment or if Arthur Andersen&#8217;s calculation of<br \/>\nCompany Net Working Capital discloses no Working Capital Shortfall, the Company<br \/>\nwill be <\/p>\n<p>                                      -31-<\/p>\n<p>deemed to have satisfied the condition to the Offer set forth in paragraph<br \/>\n(c)(x) of Annex A. The provisions of this Section 5.13(c) are exclusive of the<br \/>\nprovisions contained in Section 5.13(d).<\/p>\n<p>          (d) If Arthur Andersen&#8217;s calculation of Company Net Working Capital<br \/>\ndiscloses that there is a Working Capital Shortfall, the Majority Stockholder<br \/>\nmay within one business day, in its sole discretion, agree to the audit and<br \/>\nindemnification procedures set forth in Section 9 of the Side Letter.  If the<br \/>\nMajority Stockholder timely so agrees in writing, the Company will be deemed to<br \/>\nhave satisfied the condition to the Offer set forth in paragraph (c)(x) of Annex<br \/>\nA.  The provisions of this Section 5.13(d) are exclusive of the provisions<br \/>\ncontained in Section 5.13(c).<\/p>\n<p>                                   ARTICLE 6<\/p>\n<p>                            CONDITIONS TO THE MERGER<\/p>\n<p>          Section 6.01.  Conditions to Each Party&#8217;s Obligation to Effect the<br \/>\n                         &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\nMerger. The respective obligations of each party to consummate the Merger are<br \/>\n&#8212;&#8212;<br \/>\nsubject to the satisfaction or waiver, where permissible, prior to the Effective<br \/>\nTime, of the following conditions:<\/p>\n<p>          (a) if required by applicable law, this Agreement shall have been<br \/>\napproved by the affirmative vote of the stockholders of the Company by the<br \/>\nrequisite vote in accordance with applicable law;<\/p>\n<p>          (b) any applicable waiting period under the HSR Act relating to the<br \/>\nMerger shall have expired;<\/p>\n<p>          (c) Merger Subsidiary shall have purchased Shares tendered pursuant to<br \/>\nthe Offer, except that this condition shall not be a condition to Parent&#8217;s and<br \/>\nMerger Subsidiary&#8217;s obligations to effect the Merger if Merger Subsidiary shall<br \/>\nhave failed to purchase Shares pursuant to the Offer or, if applicable, pursuant<br \/>\nto the exercise of the Option, in breach of its obligations under this<br \/>\nAgreement; and<\/p>\n<p>          (d) no provision of any applicable law or regulation and no judgment,<br \/>\ninjunction, order or decree shall prohibit the consummation of the Merger.<\/p>\n<p>                                   ARTICLE 7<\/p>\n<p>                         TERMINATION; AMENDMENT; WAIVER<\/p>\n<p>          Section 7.01.  Termination. This Agreement may be terminated and the<br \/>\n                         &#8212;&#8212;&#8212;&#8211;<br \/>\nMerger contemplated hereby may be abandoned at any time prior to the Effective<br \/>\nTime (notwithstanding approval thereof by the stockholders of the Company):<\/p>\n<p>          (a) by mutual written consent of the Company and Parent;<\/p>\n<p>          (b) by either the Company or Parent upon notification to the other<br \/>\nparty, if the Offer has not been consummated by December 31, 2000; provided,<br \/>\nhowever, that the right to terminate this Agreement pursuant to this Section<br \/>\n7.01(b) shall not be available to any party whose <\/p>\n<p>                                      -32-<\/p>\n<p>failure to fulfill any obligation under this Agreement or the Offer has been the<br \/>\ncause of, or resulted in, the failure of the Shares to have been purchased<br \/>\npursuant to the Offer;<\/p>\n<p>          (c) by either the Company or Parent, if there shall be any law or<br \/>\nregulation that makes consummation of the Offer or the Merger illegal or<br \/>\notherwise prohibited or if any judgment, injunction, order or decree enjoining<br \/>\nParent or the Company from consummating the Offer or the Merger is entered and<br \/>\nsuch judgment, injunction, order or decree shall become final and unappealable;<br \/>\nprovided, however, that the party seeking to terminate this Agreement pursuant<br \/>\nto this Section 7.01(c) shall have used commercially reasonable efforts to<br \/>\nremove such order, decree, ruling or injunction and shall not be in violation of<br \/>\nSection 5.04; or<\/p>\n<p>          (d) by the Company: if (i) the Company is not in material breach of<br \/>\nany of its covenants or agreements in this Agreement, (ii) the board of<br \/>\ndirectors of the Company authorizes the Company, prior to the Closing Date, and<br \/>\nsubject to complying with the terms of this Agreement, to enter into a binding<br \/>\nwritten agreement concerning a Superior Proposal and the Company notifies Parent<br \/>\nin writing that it intends to enter into such an agreement, attaching the most<br \/>\ncurrent version of such agreement to such notice, and (iii) Parent does not<br \/>\nmake, within four business days of receipt of the Company&#8217;s written notification<br \/>\nof its intention to enter into such an agreement, a written and binding offer<br \/>\nthat is at least as favorable, from a financial point of view, to the<br \/>\nstockholders of the Company as the Superior Proposal. The Company agrees (x)<br \/>\nthat it will not enter into a binding agreement referred to in clause (ii) of<br \/>\nthe previous sentence until at least the first calendar day following the fourth<br \/>\nbusiness day after it has provided the written notice to Parent required<br \/>\nthereby, (y) to notify Parent promptly if its intention to enter into a written<br \/>\nagreement referred to in such notice shall change at any time after giving such<br \/>\nnotification and (z) that it will not terminate this Agreement or enter into a<br \/>\nbinding agreement referred to in clause (ii) of the previous sentence if Parent<br \/>\nhas, within the period referred to in clause (x) of this sentence, made a<br \/>\nwritten and binding offer that is at least as favorable to the Company&#8217;s<br \/>\nstockholders from a financial point of view as the Superior Proposal; or<\/p>\n<p>          (e) by Parent, at any time prior to the Closing Date, if the board of<br \/>\ndirectors of the Company shall have failed to recommend, or shall have withdrawn<br \/>\nor adversely modified its approval or recommendation of, the Offer or the Merger<br \/>\nor failed to reconfirm its recommendation of the Offer or the Merger within four<br \/>\nbusiness days after a written request by Parent to do so, or shall have resolved<br \/>\nto do any of the foregoing.<\/p>\n<p>          Section 7.02.  Effect of Termination.<br \/>\n                         &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\n          (a) In the event of termination of this Agreement and the abandonment<br \/>\nof the Merger pursuant to this Article 7, this Agreement shall become void and<br \/>\nof no effect with no liability of any party hereto (or any of its directors,<br \/>\nofficers, employees, agents, legal and financial advisors or other<br \/>\nrepresentatives) except as set forth below; provided, however, that except as<br \/>\notherwise provided herein, no such termination shall relieve any party hereto of<br \/>\nany liability or damages resulting from any willful breach of this Agreement.<\/p>\n<p>          (b) In the event that (i) a bona fide written fully-financed all-cash<br \/>\nAcquisition Proposal shall have been made to the Company or any of its<br \/>\nstockholders or any Person shall have announced an intention (whether or not<br \/>\nconditional) to make a fully-financed all-cash Acquisition <\/p>\n<p>                                      -33-<\/p>\n<p>Proposal with respect to the Company, and on or following the date of this<br \/>\nAgreement but prior to the Closing Date, such Acquisition Proposal, announcement<br \/>\nor intention is or becomes publicly known and (ii) on or following the date on<br \/>\nwhich such fully-financed all-cash Acquisition Proposal, announcement or<br \/>\nintention is or becomes publicly known, (A) this Agreement is terminated by<br \/>\neither Parent or the Company pursuant to Section 7.01(b) and if terminated by<br \/>\nParent or Merger Subsidiary, such termination shall be prior to the Closing<br \/>\nDate, and within 6 months after such termination, the Company either enters into<br \/>\na definitive agreement with respect to, or consummates, an Acquisition<br \/>\nTransaction or (B) this Agreement is terminated (x) by the Company pursuant to<br \/>\nSection 7.01(d) or (y) by Parent pursuant to Section 7.01(e), or (z) as a result<br \/>\nof the failure of the Company to satisfy any one of the conditions set forth in<br \/>\nparagraphs (iii) or (vii) of Annex A, then, subject to subsection (c) of this<br \/>\nSection 7.02, the Company (p) shall promptly, but in no event later than two<br \/>\nbusiness days after the date of such termination if terminated by Parent or<br \/>\nMerger Subsidiary and simultaneously with such termination if terminated by<br \/>\nCompany (except as otherwise provided in the proviso to this sentence) in the<br \/>\ncase of a termination pursuant to clause (B) and on the next business day after<br \/>\neither a definitive agreement with respect to an Acquisition Transaction is<br \/>\nexecuted or an Acquisition Transaction is consummated in the case of a<br \/>\ntermination pursuant to clause (A), pay Parent a termination fee of $8.0 million<br \/>\nin cash payable by wire transfer of same day funds, and (q) shall promptly, but<br \/>\nin no event later than two business days after being notified of such by Parent,<br \/>\npay all of the documented out-of-pocket third party charges and expenses<br \/>\nreasonably incurred by Parent or Merger Subsidiary in connection with this<br \/>\nAgreement and the Stockholders Agreement and the transactions contemplated by<br \/>\nthis Agreement and the Stockholders Agreement, including, without limitation,<br \/>\nfees and expenses of accountants, attorneys and financial advisors, up to a<br \/>\nmaximum of $1,500,000, in the aggregate. The Company acknowledges that the<br \/>\nagreements contained in this Section 7.02(b) are an integral part of the<br \/>\ntransactions contemplated by this Agreement, and that, without these agreements,<br \/>\nParent and Merger Subsidiary would not enter into this Agreement; accordingly,<br \/>\nif the Company fails to promptly pay the amount due pursuant to this Section<br \/>\n7.02, and, in order to obtain such payment, Parent or Merger Sub commences a<br \/>\nsuit which results in a binding nonappealable judgment rendered by a court of<br \/>\ncompetent jurisdiction against the Company for the fee set forth in this<br \/>\nparagraph (b) the Company shall pay to Parent or Merger Subsidiary its<br \/>\nreasonable costs and expenses (including attorneys&#8217; fees) in connection with<br \/>\nsuch suit, together with interest on the amount of the fee at the prime rate of<br \/>\nCitibank, N.A. in effect on the date such payment was required to be made.<\/p>\n<p>          (c) Parent agrees that the payment provided for in paragraph (b) of<br \/>\nthis Section shall be the sole and exclusive remedy of Parent upon termination<br \/>\nof this Agreement pursuant to Sections 7.01(b), 7.01 (d) or 7.01(e) and such<br \/>\nremedy shall be limited to the aggregate of the sums stipulated in paragraph (b)<br \/>\nof this Section.  Except as contemplated by the immediately preceding sentence,<br \/>\nnothing herein shall relieve any party from liability for the willful and<br \/>\nknowing breach of any of its representations, warranties, covenants or<br \/>\nagreements set forth in this Agreement. In no event shall the Company be<br \/>\nrequired to pay to Parent more than one termination fee pursuant to this<br \/>\nSection.<\/p>\n<p>          Section 7.03.  Amendment. To the extent permitted by applicable law,<br \/>\n                         &#8212;&#8212;&#8212;<br \/>\nthis Agreement may be amended by the parties at any time before or after<br \/>\napproval of this Agreement by the stockholders of the Company; provided,<br \/>\nhowever, that after any such stockholder approval, no amendment shall be made<br \/>\nwhich by law requires further approval of the Company&#8217;s stockholders without the<br \/>\napproval of such stockholders. This Agreement may not be amended except by an<br \/>\ninstrument in writing signed on behalf of each of the parties.<\/p>\n<p>          Section 7.04.  Extension; Waiver. At any time prior to the Effective<br \/>\n                         &#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\nTime, a party hereto may (a) extend the time for the performance of any of the<br \/>\nobligations or other acts of <\/p>\n<p>                                      -34-<\/p>\n<p>the other parties hereto, (b) waive any inaccuracies in the representations and<br \/>\nwarranties contained herein or in any document delivered pursuant hereto by any<br \/>\nother party or (c) subject to Section 7.03, waive compliance by any other party<br \/>\nwith any of the agreements or conditions contained herein. Any agreement on the<br \/>\npart of any party to any such extension or waiver shall be valid only if set<br \/>\nforth in an instrument in writing signed on behalf of such party. The failure of<br \/>\nany party to this Agreement assert any of its rights under this Agreement or<br \/>\notherwise shall not constitute a waiver of such rights.<\/p>\n<p>          Section 7.05.  Procedure for Termination, Extension or Waiver.<br \/>\n                         &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\nA termination of this Agreement pursuant to Section 7.01, an amendment of this<br \/>\nAgreement pursuant to Section 7.03 or an extension or waiver pursuant to Section<br \/>\n7.04 in order to be effective shall require, in the case of Parent or the<br \/>\nCompany, action by its Board of Directors or, with respect to any amendment of<br \/>\nthis Agreement, a duly authorized committee of its Board of Directors.<\/p>\n<p>                                   ARTICLE 8<\/p>\n<p>                                 MISCELLANEOUS<\/p>\n<p>          Section 8.01.  Non-Survival of Representations and Warranties. None of<br \/>\n                         &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\nthe representations and warranties made in this Agreement or in any instrument<br \/>\ndelivered pursuant to this Agreement shall survive after the Effective Time.<br \/>\nThis Section 8.01 shall not limit any covenant or agreement of the parties<br \/>\nhereto that by its terms contemplates performance after the Effective Time.<\/p>\n<p>          Section 8.02.  Entire Agreement; Assignment. This Agreement (including<br \/>\n                         &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\nthe Company Disclosure Schedule and the Parent Disclosure Schedule), the<br \/>\nStockholder Agreement and, to the extent contemplated in Section 5.03(b), the<br \/>\nConfidentiality Agreement, (a) constitute the entire agreement among the parties<br \/>\nwith respect to the subject matter hereof and supersede all other prior<br \/>\nagreements and understandings, both written and oral, among the parties or any<br \/>\nof them with respect to the subject matter hereof and (b) shall not be assigned<br \/>\nby operation of law or otherwise, provided, however, that Parent or Merger<br \/>\nSubsidiary may assign any of their rights and obligations to any direct or<br \/>\nindirect wholly-owned subsidiary of Parent, but no such assignment shall relieve<br \/>\nParent or Merger Subsidiary of its obligations hereunder. Any of Parent, Merger<br \/>\nSubsidiary or any direct or indirect wholly-owned subsidiary of Parent may<br \/>\npurchase Shares under the Offer.<\/p>\n<p>          Section 8.03.  Validity. The invalidity or unenforceability of any<br \/>\n                         &#8212;&#8212;&#8211;<br \/>\nprovision of this Agreement shall not affect the validity or enforceability of<br \/>\nany other provisions of this Agreement, which shall remain in full force and<br \/>\neffect.<\/p>\n<p>                                      -35-<\/p>\n<p>          Section 8.04.  Notices. All notices, requests, claims, demands and<br \/>\n                         &#8212;&#8212;-<br \/>\nother communications hereunder shall be in writing and shall be deemed to have<br \/>\nbeen duly given when delivered in person, by facsimile transmission with<br \/>\nconfirmation of receipt, by overnight courier (with delivery confirmed), or by<br \/>\nregistered or certified mail (postage prepaid, return receipt requested) to the<br \/>\nrespective parties as follows:<\/p>\n<p>          (a) To Parent or the Merger Subsidiary:<\/p>\n<p>          Merck &amp; Co., Inc.<br \/>\n          One Merck Drive<br \/>\n          P.O. Box 100 W53AB-05<br \/>\n          Whitehouse Station, NJ  08889<br \/>\n          Attention: Celia A. Colbert<br \/>\n          Assistant General Counsel and<br \/>\n          Secretary<br \/>\n          Fax:  (908) 735-1246<\/p>\n<p>          With a copy to:<\/p>\n<p>          Fried, Frank, Harris, Shriver<br \/>\n           &amp; Jacobson<br \/>\n          One New York Plaza<br \/>\n          New York, New York  10004<br \/>\n          Attention:  Gary P. Cooperstein, Esq.<br \/>\n          Facsimile:  (212) 859-4000<\/p>\n<p>          (b)  if to the Company:<\/p>\n<p>          ProVantage Health Services, Inc.<br \/>\n          N19 W24130 Riverwood Dr.,<br \/>\n          Waukesha, WI  53188<br \/>\n          Attention:  Jeffrey A. Jones<br \/>\n          President and Chief Executive Officer<br \/>\n          Fax:  (262) 312-3858<\/p>\n<p>          With a copy to:<\/p>\n<p>          Foley &amp; Lardner<br \/>\n          777 East Wisconsin Avenue<br \/>\n          Milwaukee, Wisconsin 53202<br \/>\n          Attention:  Jay O. Rothman, Esq.<\/p>\n<p>          Fax: (414) 297-4900<\/p>\n<p>or to such other address as the person to whom notice is given may have<br \/>\npreviously furnished to the others in writing in the manner set forth above<br \/>\n(provided that notice of any change of address shall be effective only upon<br \/>\nreceipt thereof).<\/p>\n<p>                                      -36-<\/p>\n<p>          Section 8.05.  Governing Law. This Agreement shall be governed by and<br \/>\n                         &#8212;&#8212;&#8212;&#8212;-<br \/>\nconstrued in accordance with the laws of the State of Delaware.<\/p>\n<p>          Section 8.06. Jurisdiction. Any suit, action or proceeding seeking to<br \/>\n                        &#8212;&#8212;&#8212;&#8212;<br \/>\nenforce any provision of, or based on any matter arising out of or in connection<br \/>\nwith, this Agreement or the transactions contemplated hereby may be brought<br \/>\nagainst any of the parties in any federal court located in the State of Delaware<br \/>\nor any Delaware state court, and each of the parties hereto hereby consents to<br \/>\nthe exclusive jurisdiction of such courts (and of the appropriate appellate<br \/>\ncourts therefrom) in any such suit, action or proceeding and waives any<br \/>\nobjection to venue laid therein. Process in any such suit, action or proceeding<br \/>\nmay be served on any party anywhere in the world, whether within or without the<br \/>\nState of Delaware. Without limiting the generality of the foregoing, each party<br \/>\nhereto agrees that service of process upon such party at the address referred to<br \/>\nin Section 8.04, together with written notice of such service to such party,<br \/>\nshall be deemed effective service of process upon such party.<\/p>\n<p>          Section 8.07.  Descriptive Headings. The descriptive headings herein<br \/>\n                         &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\nare inserted for convenience of reference only and shall not constitute a part<br \/>\nof or affect the meaning or interpretation of this Agreement.<\/p>\n<p>          Section 8.08.  Parties in Interest. This Agreement shall be binding<br \/>\n                         &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\nupon and inure solely to the benefit of each party hereto, and nothing in this<br \/>\nAgreement, express or implied, is intended to confer upon any other Person any<br \/>\nrights or remedies of any nature whatsoever under or by reason of this Agreement<br \/>\nexcept for Sections 2.10, 5.05 and 5.06 (which are intended to be for the<br \/>\nbenefit of the Persons entitled to therein, and may be enforced by such<br \/>\nPersons).<\/p>\n<p>          Section 8.09.  Counterparts. This Agreement may be executed in two or<br \/>\n                         &#8212;&#8212;&#8212;&#8212;<br \/>\nmore counterparts, each of which shall be deemed to be an original, but all of<br \/>\nwhich shall constitute one and the same agreement.<\/p>\n<p>          Section 8.10.  Fees and Expenses. Subject to Section 7.02, all fees,<br \/>\n                         &#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\ncosts and expenses incurred in connection with the transactions contemplated by<br \/>\nthis Agreement shall be paid by the party incurring such fees and expenses,<br \/>\nwhether or not the Offer or the Merger is consummated.<\/p>\n<p>          Section 8.11.  Enforcement of Agreement. The parties hereto agree that<br \/>\n                         &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\nmoney damages or other remedy at law would not be sufficient or adequate remedy<br \/>\nfor any breach or violation of, or a default under, this Agreement by them and<br \/>\nthat in addition to all other remedies available to them, each of them shall be<br \/>\nentitled to the fullest extent permitted by law to an injunction restraining<br \/>\nsuch breach, violation or default or threatened breach, violation or default and<br \/>\nto any other equitable relief, including, without limitation, specific<br \/>\nperformance, without bond or other security being required.<\/p>\n<p>          Section 8.12.  Waiver of Jury Trial. To the extent permitted by<br \/>\n                         &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\napplicable law, the parties hereby irrevocably waive any and all rights to trial<br \/>\nby jury in any legal proceeding arising out of or relating to this Agreement or<br \/>\nthe transactions contemplated hereby.<\/p>\n<p>          Section 8.13.  Certain Definitions. For purposes of this Agreement<br \/>\n                         &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\n(including Annex A hereto), the following terms shall have the meanings ascribed<br \/>\nto them below:<\/p>\n<p>                                      -37-<\/p>\n<p>          (a) &#8220;affiliate&#8221; of a Person shall mean (i) a Person that directly or<br \/>\nindirectly, through one or more intermediaries, controls, is controlled by, or<br \/>\nis under common control with, the first-mentioned Person and (ii) an<br \/>\n&#8220;associate&#8221;, as that term is defined in Rule 12b-2 promulgated under the<br \/>\nExchange Act as in effect on the date of this Agreement.<\/p>\n<p>          (b) &#8220;control&#8221; (including the terms &#8220;controlling&#8221;, &#8220;controlled by&#8221; and<br \/>\n&#8220;under common control with&#8221; or correlative terms) shall mean the possession,<br \/>\ndirect or indirect, of the power to direct or cause the direction of the<br \/>\nmanagement and policies of a Person, whether through ownership of voting<br \/>\nsecurities, by contract, or otherwise.<\/p>\n<p>          (c) &#8220;fully diluted&#8221; in reference to the Shares means all outstanding<br \/>\nsecurities entitled generally to vote in the election of directors of the<br \/>\nCompany on a fully diluted basis, after giving effect to the exercise or<br \/>\nconversion of all options, rights and securities exercisable or convertible into<br \/>\nsuch voting securities.<\/p>\n<p>          (d) &#8220;knowledge&#8221; shall mean the actual knowledge of the executive<br \/>\nofficers of the Company after reasonable investigation, including consultation<br \/>\nwith the principal executive officers of each of the operating Subsidiaries.<\/p>\n<p>          (e) &#8220;Lien&#8221; shall mean, with respect to any asset, any mortgage, lien,<br \/>\npledge, charge, security interest or encumbrance of any kind in respect of such<br \/>\nasset.<\/p>\n<p>          (f) &#8220;Person&#8221; shall mean an individual, a corporation, a limited<br \/>\nliability company, a partnership, an association, a trust or any other entity or<br \/>\norganization, including a government or political subdivision or any agency or<br \/>\ninstrumentality thereof.<\/p>\n<p>          (g) &#8220;subsidiary&#8221; shall mean, when used with reference to a Person<br \/>\nmeans a corporation (or other entity) the majority of the outstanding voting<br \/>\nsecurities (or equity interests) of which are owned directly or indirectly by<br \/>\nsuch Person.<\/p>\n<p>          (h) &#8220;Subsidiary&#8221; shall mean any corporation or other entity of which<br \/>\nsecurities or other ownership interests having ordinary voting power to elect a<br \/>\nmajority of the board of directors or other persons performing similar functions<br \/>\nare directly or indirectly owned by the Company.<\/p>\n<p>          (i) &#8220;Taxes&#8221; means any taxes of any kind, including but not limited to<br \/>\nthose on or measured by or referred to as income, gross receipts, capital,<br \/>\nsales, use, ad valorem, franchise, profits, license, withholding, employment,<br \/>\npayroll, premium, value added, property or windfall profits taxes, environmental<br \/>\ntransfer taxes, customs, duties or similar fees, assessments or charges of any<br \/>\nkind whatsoever, together with any interest and any penalties, additions to tax<br \/>\nor additional amounts imposed by any governmental authority, domestic or<br \/>\nforeign.<\/p>\n<p>          (j) &#8220;Tax Return&#8221; means any return, report or statement required to be<br \/>\nfiled with any governmental authority with respect to Taxes.<\/p>\n<p>                                      -38-<\/p>\n<p>          IN WITNESS WHEREOF, each of the parties has caused this Agreement to<br \/>\nbe executed on its behalf by its officer thereunto duly authorized, on the day<br \/>\nand year first above written.<\/p>\n<p>                              MERCK &amp; CO., INC.<\/p>\n<p>                              By:  \/s\/  Judy C. Lewent<br \/>\n                                   &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\n                                    Name:   Judy C. Lewent<br \/>\n                                    Title:  Senior Vice President and<br \/>\n                                            Chief Financial Officer<\/p>\n<p>                              PV ACQUISITION CORP.<\/p>\n<p>                              By:  \/s\/  Judy C. Lewent<br \/>\n                                   &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\n                                    Name:  Judy C. Lewent<br \/>\n                                    Title: President<\/p>\n<p>                              PROVANTAGE HEALTH SERVICES, INC.<\/p>\n<p>                              By:  \/s\/  Jeffrey A. Jones<br \/>\n                                   &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\n                                    Name:  Jeffrey A. Jones<br \/>\n                                    Title: President and Chief Executive<br \/>\n                                           Officer<\/p>\n<p>                                     -39-<\/p>\n<p>                                                                         ANNEX A<br \/>\n                                                                         &#8212;&#8212;-<\/p>\n<p>                            CONDITIONS TO THE OFFER<\/p>\n<p>          The capitalized terms used in this Annex A have the meanings set forth<br \/>\nin the attached Agreement, except that the term &#8220;the Agreement&#8221; shall be deemed<br \/>\nto refer to the attached Agreement.  Notwithstanding any other provision of the<br \/>\nOffer, Merger Subsidiary shall not be obligated to accept for payment or pay<br \/>\nfor, subject to Rule 14e-l(c) of the Exchange Act, any Shares, not theretofore<br \/>\naccepted for payment and may terminate or amend the Offer if (a) that number of<br \/>\nShares, which would represent at least a majority of the Shares entitled to vote<br \/>\nthat are outstanding on a fully diluted basis after giving effect to the<br \/>\nexercise or conversion of all options, rights and securities exercisable or<br \/>\nconvertible into or exchangeable for Shares or such voting securities, shall not<br \/>\nhave been validly tendered and not withdrawn immediately prior to the expiration<br \/>\nof the Offer (the &#8220;Minimum Tender Condition&#8221;), (b) any applicable waiting period<br \/>\nunder the HSR Act shall not have expired or been terminated prior to the<br \/>\nexpiration of the Offer or (c) prior to the expiration of the Offer (immediately<br \/>\nprior to the Offer in the case of clause (viii)), any of the following<br \/>\nconditions exist or shall occur:<\/p>\n<p>               (i) there shall have been entered, enforced or issued by any<br \/>\n     Governmental Entity any final non-appealable judgment, order, injunction or<br \/>\n     decree, (A) which makes illegal, restrains or prohibits the making of the<br \/>\n     Offer, the acceptance for payment of, or payment for, any Shares by Parent<br \/>\n     or Merger Subsidiary, or the consummation of the Merger, or (B) which<br \/>\n     imposes limitations on the ability of Parent or Merger Subsidiary or their<br \/>\n     respective affiliates to exercise full rights of ownership of, any Shares<br \/>\n     accepted for payment pursuant to the Offer including, without limitation,<br \/>\n     the right to vote the Shares accepted for payment by it on all matters<br \/>\n     properly presented to the stockholders of the Company or (C) which<br \/>\n     prohibits or imposes any material limitation on Parent&#8217;s, Merger<br \/>\n     Subsidiary&#8217;s or any of their respective affiliates&#8217; ownership or operation<br \/>\n     of all or any material portion of the business or assets of the Company and<br \/>\n     its Subsidiaries taken as a whole or Parent and its Subsidiaries taken as a<br \/>\n     whole except as contemplated by clause (b)(2) of Section 5.04(b) of the<br \/>\n     Merger Agreement (as limited by proviso (ii) of clause (b)(2) of such<br \/>\n     Section 5.04(b));<\/p>\n<p>               (ii)   there shall have been any pending action, litigation or<br \/>\n     proceeding brought by any Governmental Entity or any action, litigation or<br \/>\n     proceeding threatened in writing by the FTC seeking to achieve any of the<br \/>\n     consequences referred to in clauses (A) through (C) of paragraph (i) above;<br \/>\n     provided, however, Parent may not terminate the Agreement as a result of<br \/>\n     the failure to satisfy this condition prior to December 31, 2000; and<br \/>\n     further provided, however, that Parent shall comply with its obligations<br \/>\n     under Section 5.04 of the Agreement;<\/p>\n<p>               (iii)  the Company&#8217;s Board of Directors shall have modified or<br \/>\n     amended its recommendation of the Offer in any manner adverse to Parent or<br \/>\n     Merger Subsidiary or shall have withdrawn its recommendation of the Offer<br \/>\n     or shall have recommended acceptance of any Acquisition Proposal or shall<br \/>\n     have failed to reconfirm its recommendation of the Offer within four<br \/>\n     business days after a written request by Parent to do so, or shall have<br \/>\n     resolved to do any of the foregoing; or<\/p>\n<p>               (iv) (A) the representations and warranties of the Company set<br \/>\n     forth in this Agreement shall have failed to be true and correct as of the<br \/>\n     date of this Agreement and as of the consummation of the Offer (except for<br \/>\n     those representations and warranties made as of a specific date, which<br \/>\n     shall have failed to be true and correct as of such date), <\/p>\n<p>                                      -1-<\/p>\n<p>     considered without regard to any qualification by, or references to,<br \/>\n     &#8220;material,&#8221; &#8220;in all material respects&#8221; or &#8220;Company Material Adverse<br \/>\n     Effect,&#8221; except for such failures of such representations and warranties to<br \/>\n     be true and correct that individually or in the aggregate, do not have a<br \/>\n     Company Material Adverse Effect and except for General Changes or<br \/>\n     Transaction Changes or (B) the Company shall have breached or failed to<br \/>\n     comply in any material respect with any of its material obligations,<br \/>\n     covenants or agreements under the Agreement and any such breach or failure<br \/>\n     shall not have been substantially cured by the Company within five business<br \/>\n     days after Parent provides written notice to the Company of such breach or<br \/>\n     failure;<\/p>\n<p>               (v) the Merger Agreement shall have been terminated in accordance<br \/>\n     with its terms;<\/p>\n<p>               (vi) there shall have occurred any event which could reasonably<br \/>\n     be expected to have a Company Material Adverse Effect, except for General<br \/>\n     Changes or Transaction Changes;<\/p>\n<p>               (vii)  any corporation, entity, &#8220;group&#8221; or &#8220;person&#8221; (as defined<br \/>\n     in the Exchange Act), other than Parent, Merger Sub, or the shareholder<br \/>\n     that is party to the Stockholder Agreement (so long as such shareholder<br \/>\n     does not breach any of the provisions of the Stockholder Agreement), shall<br \/>\n     have acquired beneficial ownership of more than 25% of the outstanding<br \/>\n     Shares;<\/p>\n<p>               (viii)  there shall exist (A) any general suspension of, or<br \/>\n     limitation on prices for, trading in securities on any national securities<br \/>\n     exchange or in the over the counter market in the United States (other than<br \/>\n     shortening of trading hours or any trading halt resulting from a specified<br \/>\n     increase or decrease in a market index), (B) a declaration of any banking<br \/>\n     moratorium by federal or state authorities or any suspension of payments in<br \/>\n     respect of banks or any limitation (whether or not mandatory) imposed by<br \/>\n     federal or state authorities on the extension of credit by lending<br \/>\n     institutions in the United States, or (C) in the case of any of the<br \/>\n     foregoing existing at the time of the commencement of the Offer, a material<br \/>\n     acceleration or worsening thereof;<\/p>\n<p>               (ix) any provision in the Side Letter or Affiliate Agreements<br \/>\n     shall have been amended, terminated, modified or waived in a manner not<br \/>\n     contemplated by the Side Letter; or<\/p>\n<p>               (x) subject to the ability of the Majority Stockholder to timely<br \/>\n     cure any shortfall in Company Net Working Capital pursuant to Section<br \/>\n     5.13(c) or (d) of the Merger Agreement, Company Net Working Capital on the<br \/>\n     last day of the Company Fiscal Period immediately preceding the scheduled<br \/>\n     expiration of the Offer shall be less than $55.0 million.<\/p>\n<p>which, in the reasonable good faith judgment of Parent and regardless of the<br \/>\ncircumstances giving rise to any such condition, makes it inadvisable to proceed<br \/>\nwith the Offer or with such acceptance for payment, purchase of, or payment for<br \/>\nShares.  The failure by Parent or Merger Subsidiary at any time to exercise any<br \/>\nof the foregoing rights shall not be deemed a waiver of any such right, the<\/p>\n<p>                                      -2-<\/p>\n<p>waiver of any such right with respect to particular facts and other<br \/>\ncircumstances shall not be deemed a waiver with respect to any other facts and<br \/>\ncircumstances, and each such right shall be deemed an ongoing right that may be<br \/>\nasserted at any time and from time to time.<\/p>\n<p>                                      -3-<\/p>\n","protected":false},"template":"","meta":{"_acf_changed":false,"_stopmodifiedupdate":true,"_modified_date":"","_cloudinary_featured_overwrite":false},"corporate_contracts_companies":[8190,8591],"corporate_contracts_industries":[9438,9407],"corporate_contracts_types":[9622,9626],"class_list":["post-43091","corporate_contracts","type-corporate_contracts","status-publish","hentry","corporate_contracts_companies-merck---co","corporate_contracts_companies-provantage-health-services-inc","corporate_contracts_industries-health__misc","corporate_contracts_industries-drugs__pharma","corporate_contracts_types-planning","corporate_contracts_types-planning__merger"],"acf":[],"_links":{"self":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts\/43091","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts"}],"about":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/types\/corporate_contracts"}],"wp:attachment":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/media?parent=43091"}],"wp:term":[{"taxonomy":"corporate_contracts_companies","embeddable":true,"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts_companies?post=43091"},{"taxonomy":"corporate_contracts_industries","embeddable":true,"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts_industries?post=43091"},{"taxonomy":"corporate_contracts_types","embeddable":true,"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts_types?post=43091"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}